The path to personalized medicine.
paper
Cited
Public
Unavailable
- Authors
- Hamburg, Margaret A; Collins, Francis S
- Year
- 2010
- Journal
- The New England journal of medicine
- PMID
- 20551152
- DOI
- 10.1056/NEJMp1006304
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A Comprehensive Guide on Epigenetics' Precision Role in Uncommon "Rare" Cancers' Biology and Treatment Frontiers. | Hamdy NM et al. | β | 2026 | β |
| Defining Experimental Design for Human Motor Control Identification: A Novel Framework. | Cancrini A et al. | β | 2026 | β |
| DrugSurvPlot: A Novel Web-Based Platform Harnessing Drug Sensitivity Scores as Molecular Biomarkers for Pan-Cancer Survival Prognosis. | Shi Y et al. | β | 2026 | β |
| Evaluation of reported claims of sex-based differences in treatment effects across meta-analyses: a meta-research study. | Kastrati L et al. | β | 2026 | β |
| Ferroptosis and the cGAS-STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma. | Elmetwalli A | β | 2026 | β |
| Genomic Testing in Australia: A Budget Impact Analysis Using Diffusion Modeling From a Healthcare System Perspective. | Mordaunt DA et al. | β | 2026 | β |
| Innovations to improve outcomes and uptake of psychotherapies for mental disorders: a state-of-the-art review. | Cuijpers P et al. | β | 2026 | β |
| Mapping Competence in Gastrointestinal Endoscopy Nursing Practice: An Item Response Theory Analysis of Perceived Skill Acquisition and Maintenance in Italy. | Bozzetti M et al. | β | 2026 | β |
| Penalized Subgrouping of Heterogeneous Time Series. | Crawford CM et al. | β | 2026 | β |
| Platelet-Rich Plasma in the Treatment of Musculoskeletal Disease in 2025 and Beyond. | Rothrauff BB et al. | β | 2026 | β |
| Sitting and Active Meditation Practice: Utilization and Associations with Outcomes in Naturalistic and Clinical Trial Data. | Goldberg SB et al. | β | 2026 | β |
| The Emerging Role of Olfactory Receptors: From Genomics to Precision Medicine. | Dubey N et al. | β | 2026 | β |
| The Epigenetic Angle in the Precision Medicine Era for Blood Disorder Advancements. | Hamdy NM et al. | β | 2026 | β |
| Abstinence in recently detoxified AUD patients is subtended by increased inhibitory neural resources: A retrospective event-related potentials study. | Campanella S et al. | β | 2025 | β |
| A data-intelligence-intensive bioinformatics copilot system for large-scale omics research and scientific insights. | Liu Y et al. | β | 2025 | β |
| AI-powered precision medicine: utilizing genetic risk factor optimization to revolutionize healthcare. | Alsaedi S et al. | β | 2025 | β |
| A knowledge-based clinical decision support system for personalized health examination items in China: design and evaluation. | Wu D et al. | β | 2025 | β |
| A novel tool to predict lymph node metastasis in patients with prostate cancer based on clinical and 68Ga-PSMA PET/CT parameters. | Dekalo S et al. | β | 2025 | β |
| Artificial Intelligence in Medicine and Imaging Applications. | Rajpoot K | β | 2025 | β |
| A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care. | Wojcik KM et al. | β | 2025 | β |
| Clustering lung function and symptom profiles for asthma risk stratification. | Cucco A et al. | β | 2025 | β |
| Daily association between perceived control and resolution of daily stressors strengthens across a decade of adulthood. | Witzel DD et al. | β | 2025 | β |
| Digital Twins in Personalized Medicine: Bridging Innovation and Clinical Reality. | Silva A et al. | β | 2025 | β |
| Dual Nature of Mitochondrial Integrated Stress Response: Molecular Switches from Protection to Pathology. | Jeong J et al. | β | 2025 | β |
| Editorial: A Step-by-step Statistical Decision Framework for a Gender-inclusive Approach in Sport and Exercise Science Research. | Navalta JW et al. | β | 2025 | β |
| Effectiveness and safety of subcutaneous immunotherapy using a depigmented, polymerized extract of cat epithelium in allergic patients: a retrospective, real-world study. | JimΓ©nez-Blanco MA et al. | β | 2025 | β |
| Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. | Giorgino F et al. | β | 2025 | β |
| Hot-melt extruded-FDM 3D-printed polyethylene oxide tablets: Dissolution imaging analysis of swelling and drug release. | Muhamad H et al. | β | 2025 | β |
| Integrative analysis of high-dimensional RCT and RWD subject to censoring and hidden confounding. | Ye X et al. | β | 2025 | β |
| Joint quantile regression of longitudinal continuous proportions and time-to-event data: Application in medication adherence and persistence. | Burger DA et al. | β | 2025 | β |
| Longitudinal clinical trial enrollment trends across 341 US FDA-approved drugs and their guiding role in precision medicine strategies. | Zaaijer S et al. | β | 2025 | β |
| Longitudinal idiographic assessment of adolescent-dog relationships and adaptive coping for youth with social anxiety: The Teen & Dog Study protocol. | Mueller MK et al. | β | 2025 | β |
| Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria. | Bolliger M et al. | β | 2025 | β |
| M-Learning for Individual Treatment Rule With Survival Outcomes. | Zhao Z et al. | β | 2025 | β |
| NA_mCNN: Classification of Sodium Transporters in Membrane Proteins by Integrating Multi-Window Deep Learning and ProtTrans for Their Therapeutic Potential. | Malik MS et al. | β | 2025 | β |
| Novel Taurinamide-Based Compounds as Carbonic Anhydrase Inhibitors. | Akgul O et al. | β | 2025 | β |
| Optimising test intervals for individuals with type 2 diabetes: A machine learning approach. | Pedersen SM et al. | β | 2025 | β |
| Patterns of Respiratory Symptoms and Asthma Diagnosis in School-Age Children: Three Birth Cohorts. | Cucco A et al. | β | 2025 | β |
| Pharmacogenomics and risk stratification in cardiovascular care: Insights from randomized controlled trials. | Khan SA et al. | β | 2025 | β |
| Politically-targeted intergroup interventions promote social equality and engagement. | Nir N et al. | β | 2025 | β |
| Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the Personalized Advantage Index. | Wade BSC et al. | β | 2025 | β |
| Preparation of electrochemical aptamer-based sensors: a direct aryl diazonium grafting approach. | Dief EM et al. | β | 2025 | β |
| Real-world implementation of a noninvasive, AI-augmented, anemia-screening smartphone app and personalization for hemoglobin level self-monitoring. | Mannino RG et al. | β | 2025 | β |
| Reducing inequalities using an unbiased machine learning approach to identify births with the highest risk of preventable neonatal deaths. | Ramos AP et al. | β | 2025 | β |
| Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients. | SarΓΆmba JA et al. | β | 2025 | β |
| Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients. | SarΓΆmba JA et al. | β | 2025 | β |
| Spectrum of Cervical Insufficiency: Management Strategies from Asymptomatic Shortening to Emergent Membrane Prolapse. | Baroutis D et al. | β | 2025 | β |
| Towards AI-based precision rehabilitation via contextual model-based reinforcement learning. | Ye D et al. | β | 2025 | β |
| Treating Cardiovascular Disorders with Personalized Medicine. | Garg I et al. | β | 2025 | β |
| Trends in and predictors of patient pharmacogenomic test uptake in a national health care system. | Silva A et al. | β | 2025 | β |
| Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts. | Sumiyoshi T et al. | β | 2025 | β |
| Use machine learning to predict treatment outcome of early childhood caries. | Wu Y et al. | β | 2025 | β |
| Using Machine Learning to Predict Treatment Outcome in a Concatenated Dataset of Youth Anxiety Treatments. | Norris LA et al. | β | 2025 | β |
| 3D-printed dosage forms for oral administration: a review. | Pan S et al. | β | 2024 | β |
| 3D printing processes in precise drug delivery for personalized medicine. | Peng H et al. | β | 2024 | β |
| Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers. | Lee JY et al. | β | 2024 | β |
| Ancestry, ethnicity, and race: explaining inequalities in cardiometabolic disease. | Eastwood SV et al. | β | 2024 | β |
| A platform for comparing subgroup identification methodologies. | Ruberg S et al. | β | 2024 | β |
| Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset. | Sommer J et al. | β | 2024 | β |
| BackMov: Individualized Motion Capture-Based Test to Assess Low Back Pain Mobility Recovery after Treatment. | Villalba-Meneses F et al. | β | 2024 | β |
| Bayesian Multivariate Logistic Regression for Superiority and Inferiority Decision-Making under Observable Treatment Heterogeneity. | Kavelaars X et al. | β | 2024 | β |
| Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients? | Lemaitre F et al. | β | 2024 | β |
| Chemoproteomics, A Broad Avenue to Target Deconvolution. | Gao Y et al. | β | 2024 | β |
| Cognitive Behavioral Therapy for Chronic Pelvic Pain: What Is It and Does It Work? | Lackner JM et al. | β | 2024 | β |
| Comment faire entrer la mΓ©decine de prΓ©cision dans la dΓ©cision thΓ©rapeutique de routine au lit du maladeΒ ? | Lemaitre F et al. | β | 2024 | β |
| CPMKG: a condition-based knowledge graph for precision medicine. | Yang J et al. | β | 2024 | β |
| Current Management of Allergic Rhinitis. | Klimek L et al. | β | 2024 | β |
| Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development. | Puhlmann N et al. | β | 2024 | β |
| Development of the Acute Coronary Syndrome Predictive Scale. | Elyaszadeh S et al. | β | 2024 | β |
| Drug screening on digital microfluidics for cancer precision medicine. | Zhai J et al. | β | 2024 | β |
| Dysgeusia and Chronic Kidney Disease: A Scoping Review. | Sguanci M et al. | β | 2024 | β |
| Early warning of potential epidemics: A pilot application of an early warning tool to data from the pulmonary clinic of the university hospital of Thessaly, Greece. | Meletis E et al. | β | 2024 | β |
| Enzyme kinetics simulation at the scale of individual particles. | Kearney T et al. | β | 2024 | β |
| Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review. | Yasin H et al. | β | 2024 | β |
| Harnessing Senescence for Antitumor Immunity to Advance Cancer Treatment. | Prasanna PGS | β | 2024 | β |
| Knowledge and Attitudes of Secondary Schools βstudents Towards Premarital Screening and Counseling in Taiz, Yemen. | Alhetar SZM et al. | β | 2024 | β |
| Limitations of Separating Athletes into High or Low-Risk Groups based on a Cut-Off. A Clinical Commentary. | Losciale JM et al. | β | 2024 | β |
| Mindfulness-based stress reduction (MBSR) for fibromyalgia patients: The role of pain cognitions as mechanisms of change. | Taub R et al. | β | 2024 | β |
| Multi-level exploration of auricular acupuncture: from traditional Chinese medicine theory to modern medical application. | Guo K et al. | β | 2024 | β |
| PAGER-scFGA: unveiling cell functions and molecular mechanisms in cell trajectories through single-cell functional genomics analysis. | Huang F et al. | β | 2024 | β |
| Penalized robust learning for optimal treatment regimes with heterogeneous individualized treatment effects. | Li C et al. | β | 2024 | β |
| Precision nutrition-based strategy for management of human diseases and healthy aging: current progress and challenges forward. | Singh VK et al. | β | 2024 | β |
| Prescription Precision: A Comprehensive Review of Intelligent Prescription Systems. | Tantray J et al. | β | 2024 | β |
| Problems most concerning to parents of children with ADHD and emotional dysregulation in a randomized controlled trial of multinutrients: MADDY secondary analysis. | Tost G et al. | β | 2024 | β |
| Prognostic subgroups of chronic pain patients using latent variable mixture modeling within a supervised machine learning framework. | Zhao X et al. | β | 2024 | β |
| Qualitative assessment of knowledge, attitude and practice of oncologists about precision medicine in cancer patients- study from Lahore, Pakistan. | Naaem R et al. | β | 2024 | β |
| Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry. | Hua W et al. | β | 2024 | β |
| Resilience in sports: a multidisciplinary, dynamic, and personalized perspective. | Den Hartigh RJR et al. | β | 2024 | β |
| Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives. | Molla G et al. | β | 2024 | β |
| Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota. | Xie W et al. | β | 2024 | β |
| The comprehensive review on 3D printing- pharmaceutical drug delivery and personalized food and nutrition. | Murugan M et al. | β | 2024 | β |
| The evolution of ancient healing practices: From shamanism to Hippocratic medicine: A review. | Elendu C | β | 2024 | β |
| The Promise of Explainable AI in Digital Health for Precision Medicine: A Systematic Review. | Allen B | β | 2024 | β |
| The Roadmap toward Personalized Medicine: Challenges and Opportunities. | Cinti C et al. | β | 2024 | β |
| A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity. | Niazi SK | β | 2023 | β |
| An efficient genotyper and star-allele caller for pharmacogenomics. | Hari A et al. | β | 2023 | β |
| A Network Analysis of Cardiovascular Risk Factors in Patients With Heart Disease: The Role of Socioeconomic Status and Sex. | van den Houdt SCM et al. | β | 2023 | β |
| Antineuronal autoantibodies induced paraneoplasic syndrome in schizophrenia spectrum disorders: case report. | Jaballah F et al. | β | 2023 | β |
| Bayesian multilevel multivariate logistic regression for superiority decision-making under observable treatment heterogeneity. | Kavelaars X et al. | β | 2023 | β |
| Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence. | MΓ©ndez HernΓ‘ndez R et al. | β | 2023 | β |
| [Chronic tinnitus: An interplay between somatic and psychological factors]. | Boecking B et al. | β | 2023 | β |
| Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. | Niazi SK et al. | β | 2023 | β |
| Customizable 3D Printed Implants Containing Triamcinolone Acetonide: Development, Analysis, Modification, and Modeling of Drug Release. | Ponsar H et al. | β | 2023 | β |
| Digital healthcare for dementia and cognitive impairment: A scoping review. | Sohn M et al. | β | 2023 | β |
| Elastic integrative analysis of randomised trial and real-world data for treatment heterogeneity estimation. | Yang S et al. | β | 2023 | β |
| Epidermal Wearable Biosensors for Monitoring Biomarkers of Chronic Disease in Sweat. | Yuan X et al. | β | 2023 | β |
| Expectations from a Home Cooking Program: Qualitative Analyses of Perceptions from Participants in "Action" and "Contemplation" Stages of Change, before Entering a Bi-Center Randomized Controlled Trial. | Polak R et al. | β | 2023 | β |
| Functionalized photosensitive metal-organic framework as a theranostic nanoplatform for turn-on detection of MicroRNA and photodynamic therapy. | Yang C et al. | β | 2023 | β |
| Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases. | Kiiskinen T et al. | β | 2023 | β |
| Implantable Hydrogel-Protective DNA Aptamer-Based Sensor Supports Accurate, Continuous Electrochemical Analysis of Drugs at Multiple Sites in Living Rats. | Li S et al. | β | 2023 | β |
| Implementation of pharmacogenetic testing in medication reviews in a hospital setting. | HjemΓ₯s BJ et al. | β | 2023 | β |
| Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience. | Villalona-Calero MA et al. | β | 2023 | β |
| In vitro high-content tissue models to address precision medicine challenges. | Afewerki S et al. | β | 2023 | β |
| Meta-topologies define distinct anatomical classes of brain tumours linked to histology and survival. | Kernbach JM et al. | β | 2023 | β |
| Microfluidics engineering towards personalized oncology-a review. | Mishra S et al. | β | 2023 | β |
| Monitoring Cardiac Biomarkers with Aptamer-Based Molecular Pendulum Sensors. | Mahmud A et al. | β | 2023 | β |
| Multiplexing AAV Serotype-Specific Neutralizing Antibodies in Preclinical Animal Models and Humans. | Kuoch H et al. | β | 2023 | β |
| Personalized Injury Reduction Strategies in Sports Medicine: Lessons Learned from Advances in Breast Cancer Treatment: A Clinical Commentary. | Bullock G et al. | β | 2023 | β |
| Personalized Medicine: Advanced Treatment Strategies to Revolutionize Healthcare. | Singh AK et al. | β | 2023 | β |
| PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework. | Dingemans AJM et al. | β | 2023 | β |
| Platinum Black/Gold Nanoparticles/Polyaniline Modified Electrochemical Microneedle Sensors for Continuous In Vivo Monitoring of pH Value. | Ming T et al. | β | 2023 | β |
| Precision periodontal care: from omics discoveries to chairside diagnostics. | Bostanci N et al. | β | 2023 | β |
| Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function. | Ali S et al. | β | 2023 | β |
| Predictors and moderators of three online interventions for eating disorder symptoms in a randomized controlled trial. | Rohrbach PJ et al. | β | 2023 | β |
| Public perceptions and attitudes of the national project of bio-big data: A nationwide survey in the Republic of Korea. | Yang JH et al. | β | 2023 | β |
| Quantitative risk analysis of treatment plans for patients with tumor by mining historical similar patients from electronic health records using federated learning. | Liu Y et al. | β | 2023 | β |
| TARGET National: A UK-wide Liquid-based Molecular Profiling Programme: On Behalf of the TARGET National Consortium. | Ortega-Franco A et al. | β | 2023 | β |
| The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy. | Li J et al. | β | 2023 | β |
| The Evolution of Current Concept of the Reconstructive Ladder in Plastic Surgery: The Emerging Role of Translational Medicine. | De Francesco F et al. | β | 2023 | β |
| The use of biomarkers to guide precision treatment for tobacco use. | Siegel SD et al. | β | 2023 | β |
| Toward Precision Characterization and Treatment of Psychopathology: A Path Forward and Integrative Framework of the Hierarchical Taxonomy of Psychopathology and the Research Domain Criteria. | Hagerty SL | β | 2023 | β |
| Treatment effect modifiers for individuals with acute low back pain: secondary analysis of the TARGET trial. | Beneciuk JM et al. | β | 2023 | β |
| Using ChatGPT to predict the future of personalized medicine. | Patrinos GP et al. | β | 2023 | β |
| Wearable sensor platforms for real-time monitoring and early warning of metabolic disorders in humans. | Ayyanu R et al. | β | 2023 | β |
| What caregivers like the most (and least) about cognitive behavioral therapy for youth anxiety: A mixed methods approach. | Norris LA et al. | β | 2023 | β |
| World Trade Center responders in their own words: predicting PTSD symptom trajectories with AI-based language analyses of interviews. | Son Y et al. | β | 2023 | β |
| 3D printing of pharmaceuticals: approach from bench scale to commercial development. | Pawar R et al. | β | 2022 | β |
| A common factors perspective on mindfulness-based interventions. | Goldberg SB | β | 2022 | β |
| A Data-Driven Pipeline to Discover Treatment Variations and the Associated Contributing Factors Balanced with Optimal Granularity. | Fan H et al. | β | 2022 | β |
| A deep learning model trained on only eight whole-slide images accurately segments tumors: wise data use versus big data | Perennec T et al. | β | 2022 | β |
| Airline Point-of-Care System on Seat Belt for Hybrid Physiological Signal Monitoring. | Ji X et al. | β | 2022 | β |
| A Machine-Learning Approach for Estimating Subgroup- and Individual-Level Treatment Effects: An Illustration Using the 65 Trial. | Sadique Z et al. | β | 2022 | β |
| Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE). | Patel BK et al. | β | 2022 | β |
| A web app-based music intervention reduces experimental thermal pain: AΒ randomized trial on preferred versus least-liked music style. | Soyeux O et al. | β | 2022 | β |
| Blind-Watermarking-Proof-of-Concept of a Novel Approach to Ensure Batch Traceability for 3D Printed Tablets. | Windolf H et al. | β | 2022 | β |
| Can we Reconcile Evidence-based Medicine with Personalized Medicine: Poised on a Cusp! | Kulkarni AP et al. | β | 2022 | β |
| Current treatment strategies for seasonal allergic rhinitis: where are we heading? | Ridolo E et al. | β | 2022 | β |
| Data Dentistry: How Data Are Changing Clinical Care and Research. | Schwendicke F et al. | β | 2022 | β |
| DEMA: a distance-bounded energy-field minimization algorithm to model and layout biomolecular networks with quantitative features. | Weng Z et al. | β | 2022 | β |
| Depth importance in precision medicine (DIPM): a tree- and forest-based method for right-censored survival outcomes. | Chen V et al. | β | 2022 | β |
| Design and development of 3D-printed bento box model for controlled drug release of propranolol HCl following pharmacopeia dissolution guidelines. | Kraisit P et al. | β | 2022 | β |
| Effectiveness and cost-effectiveness of a web-based routine assessment with integrated recommendations for action for depression and anxiety (RehaCAT+): protocol for a cluster randomised controlled trial for patients with elevated depressive symptoms in rehabilitation facilities. | Knauer J et al. | β | 2022 | β |
| Efficient Pairwise Neuroimage Analysis Using the Soft Jaccard Index and 3D Keypoint Sets. | Chauvin L et al. | β | 2022 | β |
| Electronic Textiles for Wearable Point-of-Care Systems. | Chen G et al. | β | 2022 | β |
| Federated Random Forests can improve local performance of predictive models for various healthcare applications. | Hauschild AC et al. | β | 2022 | β |
| From cryptogenic to ESUS: Toward precision medicine? | Timsit S | β | 2022 | β |
| Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program. | Park KH et al. | β | 2022 | β |
| Hormonal contraceptive usage influences stress hormone effects on cognition and emotion. | Jentsch VL et al. | β | 2022 | β |
| Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism. | Watanabe K et al. | β | 2022 | β |
| Impact of preference for yoga or cognitive behavioral therapy in patients with generalized anxiety disorder on treatment outcomes and engagement. | Szuhany KL et al. | β | 2022 | β |
| Individual differences in postoperative recovery trajectories for adult symptomatic lumbar scoliosis. | Greenberg JK et al. | β | 2022 | β |
| Investigating Microtemporal Processes Underlying Health Behavior Adoption and Maintenance: Protocol for an Intensive Longitudinal Observational Study. | Wang S et al. | β | 2022 | β |
| Latent Profile/Class Analysis Identifying Differentiated Intervention Effects. | Yang Q et al. | β | 2022 | β |
| Non-asymptotic Properties of Individualized Treatment Rules from Sequentially Rule-Adaptive Trials. | Gao D et al. | β | 2022 | β |
| Optimized 3D Bioprinting Technology Based on Machine Learning: A Review of Recent Trends and Advances. | Shin J et al. | β | 2022 | β |
| PAGER Web APP: An Interactive, Online Gene Set and Network Interpretation Tool for Functional Genomics. | Yue Z et al. | β | 2022 | β |
| Personalization of renal replacement therapy initiation: a secondary analysis of the AKIKI and IDEAL-ICU trials. | Grolleau F et al. | β | 2022 | β |
| Personalized Brain-Computer Interface and Its Applications. | Ma Y et al. | β | 2022 | β |
| Pharmacogenetics of Antipsychotic Treatment in Schizophrenia. | Elsheikh SSM et al. | β | 2022 | β |
| Precision Medicine and Sickle Cell Disease. | El Hoss S et al. | β | 2022 | β |
| Precision Medicine: Historiography of Life Sciences and the Geneticization of the Clinics. | LΓΆwy I | β | 2022 | β |
| Precision medicine in trauma: a transformational frontier in patient care, education, and research. | Davis CS et al. | β | 2022 | β |
| Precision Rehabilitation: Optimizing Function, Adding Value to Health Care. | French MA et al. | β | 2022 | β |
| Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults. | Khan SS et al. | β | 2022 | β |
| Prognostic Nomogram of Osteocarcinoma after Surgical Treatment. | Wu Q et al. | β | 2022 | β |
| Recent progress and perspectives of continuous in vivo testing device. | Ming T et al. | β | 2022 | β |
| RNAscope for VEGF-A Detection in Human Tumor Bioptic Specimens. | Annese T et al. | β | 2022 | β |
| Robust inference of conditional average treatment effects using dimension reduction. | Huang MY et al. | β | 2022 | β |
| Scaffolds in Periodontal Regenerative Treatment. | Yamada S et al. | β | 2022 | β |
| Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process. | Mandal PK et al. | β | 2022 | β |
| Scoping study of definitions of social participation: update and co-construction of an interdisciplinary consensual definition. | Levasseur M et al. | β | 2022 | β |
| Semiparametric single-index models for optimal treatment regimens with censored outcomes. | Wang J et al. | β | 2022 | β |
| Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047). | Sa JK et al. | β | 2022 | β |
| The diagnostic importance of pathogenic variants and variant coexistence determined by NGS-based liquid biopsy approach in patients with lung adenocarcinoma. | Cine N et al. | β | 2022 | β |
| The fast-growing field of photo-driven theranostics based on aggregation-induced emission. | Zhang Z et al. | β | 2022 | β |
| The Idiosyncrasy Principle: A New Look at Qualia. | Salti M et al. | β | 2022 | β |
| The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets. | Ito K et al. | β | 2022 | β |
| Toward Precision Medicine in ADHD. | Buitelaar J et al. | β | 2022 | β |
| Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapy. | Wibbelink CJM et al. | β | 2022 | β |
| Translational research in nephrology: prognosis. | Tripepi G et al. | β | 2022 | β |
| Treatment resistance in psychiatry: state of the art and new directions. | Howes OD et al. | β | 2022 | β |
| Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence. | Abdulrahman H et al. | β | 2022 | β |
| 3D Printed Personalized Medicine for Cancer: Applications for Betterment of Diagnosis, Prognosis and Treatment. | Bhuskute H et al. | β | 2021 | β |
| Adaptive penalization in high-dimensional regression and classification with external covariates using variational Bayes. | Velten B et al. | β | 2021 | β |
| A Deep Neural Network-Based Method for Prediction of Dementia Using Big Data. | Kim J et al. | β | 2021 | β |
| Advances in single-molecule fluorescent nanosensors. | Liu M et al. | β | 2021 | β |
| A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals. | Poudineh M et al. | β | 2021 | β |
| Aging-Related Changes in the Association between Negative Affect and Response Time Inconsistency in Older Adulthood. | Cerino ES et al. | β | 2021 | β |
| Aptamer-modified DNA tetrahedra-gated metal-organic framework nanoparticle carriers for enhanced chemotherapy or photodynamic therapy. | Zhang P et al. | β | 2021 | β |
| Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features. | Deste G et al. | β | 2021 | β |
| Basic and Preclinical Research for Personalized Medicine. | Lattanzi W et al. | β | 2021 | β |
| Brief breath awareness training yields poorer working memory performance in the context of acute stress. | Goldberg SB et al. | β | 2021 | β |
| Consolidating and Upscaling Molecular Research Capacity in Nigeria: On Who's Account? | Chukwudi CU | β | 2021 | β |
| Cultural conformity and cannabis care in the wake of intractable pediatric epilepsy. | Sobo EJ | β | 2021 | β |
| Current developments in delivering customized care: a scoping review. | Minvielle E et al. | β | 2021 | β |
| Daily linkages among high and low arousal affect and subjective cognitive complaints. | Cerino ES et al. | β | 2021 | β |
| Data Integration Challenges for Machine Learning in Precision Medicine. | MartΓnez-GarcΓa M et al. | β | 2021 | β |
| Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms. | Melita G et al. | β | 2021 | β |
| Dual-Channel Theranostic System for Quantitative Self-Indication and Low-Temperature Synergistic Therapy of Cancer. | Wang C et al. | β | 2021 | β |
| Estimation and Optimization of Composite Outcomes. | Luckett DJ et al. | β | 2021 | β |
| Evaluation of Single Sample Network Inference Methods for Metabolomics-Based Systems Medicine. | Jahagirdar S et al. | β | 2021 | β |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. | Kahraman Γetin N et al. | β | 2021 | β |
| Exploring End-Group Effect of Alkanethiol Self-Assembled Monolayers on Electrochemical Aptamer-Based Sensors in Biological Fluids. | Li S et al. | β | 2021 | β |
| Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer. | Tamura T et al. | β | 2021 | β |
| FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology. | Li D et al. | β | 2021 | β |
| From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model. | Di Stasio GD et al. | β | 2021 | β |
| Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week. | Januzzi JL et al. | β | 2021 | β |
| Gene Therapy as an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges. | Sheikh-Hosseini M et al. | β | 2021 | β |
| High-throughput framework forΒ genetic analyses of adverse drug reactions using electronic health records. | Zheng NS et al. | β | 2021 | β |
| Imaging-Based Outcome Prediction of Acute Intracerebral Hemorrhage. | Nawabi J et al. | β | 2021 | β |
| Improved doubly robust estimation in learning optimal individualized treatment rules. | Pan Y et al. | β | 2021 | β |
| Improving the quality of care for patients requiring continuous renal replacement therapy. | Neyra JA et al. | β | 2021 | β |
| Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System? | Just KS et al. | β | 2021 | β |
| Informatics Management of Tumor Specimens in the Era of Big Data: Challenges and Solutions. | Zhang PF et al. | β | 2021 | β |
| Label-Free Identification of Single Mononucleotides by Nanoscale Electrophoresis. | Choi J et al. | β | 2021 | β |
| Machine learning applications for therapeutic tasks with genomics data. | Huang K et al. | β | 2021 | β |
| MCQ-Balance: a method to monitor patients with balance disorders and improve clinical interpretation of posturography. | De la Torre J et al. | β | 2021 | β |
| Mechanisms of change and heterogeneous treatment effects in psychodynamic and cognitive behavioural therapy for patients with depressive disorder: a randomized controlled trial. | RΓΈssberg JI et al. | β | 2021 | β |
| Mindfulness-Based Stress Reduction for Systemic Lupus Erythematosus: A Mixed-Methods Pilot Randomized Controlled Trial of an Adapted Protocol. | Taub R et al. | β | 2021 | β |
| Moderated Network Models. | Haslbeck JMB et al. | β | 2021 | β |
| Multi-omics approach to precision medicine for immune-mediated diseases. | Ota M et al. | β | 2021 | β |
| Pain Management for Dental Medicine in 2021: Opioids, Coronavirus and Beyond. | Scrivani SJ et al. | β | 2021 | β |
| Patient-Reported Factors Associated with the Onset of Hyperfunctional Voice Disorders. | Kridgen S et al. | β | 2021 | β |
| Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes. | Bizzarri M et al. | β | 2021 | β |
| Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling. | Steyerberg EW et al. | β | 2021 | β |
| Personalized Early AAC Intervention to Build Language and Literacy Skills: A Case Study of a 3-Year-Old with Complex Communication Needs. | Light J et al. | β | 2021 | β |
| Personalized medicine and allergen immunotherapy: the beginning of a new era? | Incorvaia C et al. | β | 2021 | β |
| Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model. | Incorvaia C et al. | β | 2021 | β |
| Personalized medicine in cardiovascular disease: review of literature. | Sheikhy A et al. | β | 2021 | β |
| Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients. | Bertsimas D et al. | β | 2021 | β |
| Personalized treatment selection in routine care: Integrating machine learning and statistical algorithms to recommend cognitive behavioral or psychodynamic therapy. | Schwartz B et al. | β | 2021 | β |
| Precision and personalized assessment, diagnosis and treatment in psychiatry. | Fountoulakis KN et al. | β | 2021 | β |
| Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health. | Traversi D et al. | β | 2021 | β |
| Predicting Drug Release from 3D Printed Oral Medicines Based on the Surface Area to Volume Ratio of Tablet Geometry. | Windolf H et al. | β | 2021 | β |
| Predicting Treatment Outcomes Using Explainable Machine Learning in Children with Asthma. | LovriΔ M et al. | β | 2021 | β |
| Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap? | Hersey M et al. | β | 2021 | β |
| QuASeR: Quantum Accelerated de novo DNA sequence reconstruction. | Sarkar A et al. | β | 2021 | β |
| Recent scientific/intellectual movements in biomedicine. | Au L | β | 2021 | β |
| Seeing the Whole Elephant: a scoping review of behavioral treatments for pediatric insomnia. | Meltzer LJ et al. | β | 2021 | β |
| Social Cognition Training for Enhancing Affective and Cognitive Theory of Mind in Schizophrenia: A Systematic Review and a Meta-Analysis. | d'Arma A et al. | β | 2021 | β |
| Standardization and Personalized Medicine Using Quantitative EEG in Clinical Settings. | Keizer AW | β | 2021 | β |
| Stop Codon Context-Specific Induction of Translational Readthrough. | Schilff M et al. | β | 2021 | β |
| The FutureS of healthcare. | Schiavone F et al. | β | 2021 | β |
| Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment. | Lisoway AJ et al. | β | 2021 | β |
| Turning liabilities into opportunities: Off-target based drug repurposing in cancer. | Palve V et al. | β | 2021 | β |
| Ultrasensitive detection of SARS-CoV-2 RNA and antigen using single-molecule optofluidic chip. | Meena GG et al. | β | 2021 | β |
| Use of cognitive event-related potentials in the management of psychiatric disorders: Towards an individual follow-up and multi-component clinical approach. | Campanella S | β | 2021 | β |
| Variability in Cognitive Performance on Mobile Devices Is Sensitive to Mild Cognitive Impairment: Results From the Einstein Aging Study. | Cerino ES et al. | β | 2021 | β |
| What matters to patients? A mixed method study of the importance and consideration of oncology patient demands. | Waelli M et al. | β | 2021 | β |
| 3D printing promotes the development of drugs. | Zhu X et al. | β | 2020 | β |
| 3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing. | El Aita I et al. | β | 2020 | β |
| Adaptive in vivo device for theranostics of inflammation: Real-time monitoring of interferon-Ξ³ and aspirin. | Cao C et al. | β | 2020 | β |
| Adaptive response of resistant cancer cells to chemotherapy. | Chern YJ et al. | β | 2020 | β |
| Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling. | Zhao L et al. | β | 2020 | β |
| Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study. | Just KS et al. | β | 2020 | β |
| A Feasibility Study of an Extrusion-Based Fabrication Process for Personalized Drugs. | Yu I et al. | β | 2020 | β |
| An Experimental Analogue Study on the "Dose-Response Relationship" of Different Therapeutic Instructions for Pain Exposures: The More, The Better? | KΓΆrfer K et al. | β | 2020 | β |
| Antifouling Strategies for Selective <i>In Vitro</i> and <i>In Vivo</i> Sensing. | Jiang C et al. | β | 2020 | β |
| Applying the Minimal Detectable Change of a Static and Dynamic Balance Test Using a Portable Stabilometric Platform to Individually Assess Patients with Balance Disorders. | De la Torre J et al. | β | 2020 | β |
| A Precision Medicine Approach to Rhinitis Evaluation and Management. | Crisci CD et al. | β | 2020 | β |
| A Precision Medicine Approach to SARS-CoV-2 Pandemic Management. | Crisci CD et al. | β | 2020 | β |
| Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework. | van der Wouden CH et al. | β | 2020 | β |
| A WAO - ARIA - GA<sup>2</sup>LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020. | Steering Committee Authors et al. | β | 2020 | β |
| Benchtop-fabricated lipid-based electrochemical sensing platform for the detection of membrane disrupting agents. | Saem S et al. | β | 2020 | β |
| Big Data and Artificial Intelligence Modeling for Drug Discovery. | Zhu H | β | 2020 | β |
| Biomimetic Nanotechnology toward Personalized Vaccines. | Zhou J et al. | β | 2020 | β |
| Clinical Genome Data Model (cGDM) provides Interactive Clinical Decision Support for Precision Medicine. | Kim HJ et al. | β | 2020 | β |
| Comprehensive pharmacogenomic characterization of gastric cancer. | Sa JK et al. | β | 2020 | β |
| Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. | Moradi Kashkooli F et al. | β | 2020 | β |
| Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening. | Forsythe S et al. | β | 2020 | β |
| Disproportionate positive feedbackΒ facilitates sense of agency and performance for a reaching movement task with a virtual hand. | Nataraj R et al. | β | 2020 | β |
| Enabling Technologies for Personalized and Precision Medicine. | Ho D et al. | β | 2020 | β |
| Ethnic delineation of primary glioblastoma genome. | Koo H et al. | β | 2020 | β |
| Examining the Use of Real-World Evidence in the Regulatory Process. | Beaulieu-Jones BK et al. | β | 2020 | β |
| Feasibility Analysis of CareToy-Revised Early Intervention in Infants at High Risk for Cerebral Palsy. | Beani E et al. | β | 2020 | β |
| Fundamentals and Current Strategies for Peripheral Nerve Repair and Regeneration. | Carvalho CR et al. | β | 2020 | β |
| How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial. | Marrero RJ et al. | β | 2020 | β |
| Hypoglossal Nerve Stimulation in the Treatment of Obstructive Sleep Apnea: Patient Selection and New Perspectives. | Baptista PM et al. | β | 2020 | β |
| iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research. | Chen X et al. | β | 2020 | β |
| Investigating associations between personality and the efficacy of interventions for cognitive ageing: A systematic review. | Marr C et al. | β | 2020 | β |
| Latent Profiles of Health and Reproductive Risk and Protective Factors among Women in Appalachia. | Linn BK et al. | β | 2020 | β |
| Ligand-Installed Nanocarriers toward Precision Therapy. | Mi P et al. | β | 2020 | β |
| Linking Personality Traits to Individual Differences in Affective Spaces. | Levine SM et al. | β | 2020 | β |
| Method for Vertical Calibration of Laser-Projection Transnasal Fiberoptic High-Speed Videoendoscopy. | Ghasemzadeh H et al. | β | 2020 | β |
| Moderators of Improvement From Mindfulness-Based vs Traditional Cognitive Behavioral Therapy for the Treatment of Provoked Vestibulodynia. | Brotto LA et al. | β | 2020 | β |
| Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer. | Baart VM et al. | β | 2020 | β |
| Mouse Systems Genetics as a Prelude to Precision Medicine. | Li H et al. | β | 2020 | β |
| Non-destructive dose verification of two drugs within 3D printed polyprintlets. | Trenfield SJ et al. | β | 2020 | β |
| On-demand fully customizable drug tablets via 3D printing technology for personalized medicine. | Tan YJN et al. | β | 2020 | β |
| On the Road to Personalized Psychotherapy: A Research Agenda Based on Cognitive Behavior Therapy for Depression. | Huibers MJH et al. | β | 2020 | β |
| People with obsessive-compulsive disorder often remain symptomatic following psychological treatment: A clinical significance analysis of manualised psychological interventions. | Fisher PL et al. | β | 2020 | β |
| Personality Moderates Intervention Effects on Cognitive Function: A 6-Week Conversation-Based Intervention. | Cerino ES et al. | β | 2020 | β |
| Personalized networks of eating disorder symptoms predicting eating disorder outcomes and remission. | Levinson CA et al. | β | 2020 | β |
| Personalized treatment for coronary artery disease patients: a machine learning approach. | Bertsimas D et al. | β | 2020 | β |
| PGxMine: Text mining for curation of PharmGKB. | Lever J et al. | β | 2020 | β |
| Precision medicine in cow's milk allergy. | D'Auria E et al. | β | 2020 | β |
| Predicting personalized process-outcome associations in psychotherapy using machine learning approaches-A demonstration. | Rubel JA et al. | β | 2020 | β |
| Preparation and characterization of indomethacin loaded films by piezoelectric inkjet printing: a personalized medication approach. | Arshad MS et al. | β | 2020 | β |
| Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases. | Sell SL et al. | β | 2020 | β |
| Pro-organic radical contrast agents ("pro-ORCAs") for real-time MRI of pro-drug activation in biological systems. | Nguyen HV et al. | β | 2020 | β |
| Real-time particle-by-particle detection of erythrocyte-camouflaged microsensor with extended circulation time in the bloodstream. | Di W et al. | β | 2020 | β |
| Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers. | Gopalan D et al. | β | 2020 | β |
| Screening for and Personalizing Prevention of Adolescent Depression. | Hankin BL | β | 2020 | β |
| Separation Anxiety Symptom Profiles and Parental Accommodation Across Pediatric Anxiety Disorders. | Phillips KE et al. | β | 2020 | β |
| Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare. | Cirillo D et al. | β | 2020 | β |
| Solid-Phase Microextraction Enables Isolation of BRAF V600E Circulating Tumor DNA from Human Plasma for Detection with a Molecular Beacon Loop-Mediated Isothermal Amplification Assay. | Varona M et al. | β | 2020 | β |
| Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer. | Cubillos-Angulo JM et al. | β | 2020 | β |
| The Behavior and Mind Health (BeMIND) study: Methods, design and baseline sample characteristics of a cohort study among adolescents and young adults. | Beesdo-Baum K et al. | β | 2020 | β |
| The Current Status of Genes and Genetic Testing in Emergency Medicine: A Narrative Review. | Aghamir SMK et al. | β | 2020 | β |
| The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. | Siegel SD et al. | β | 2020 | β |
| Treatment of personality pathology through the lens of the hierarchical taxonomy of psychopathology: Developing a research agenda. | Mullins-Sweatt SN et al. | β | 2020 | β |
| Using the Personalized Advantage Index for Individual Treatment Allocation to Blended Treatment or Treatment as Usual for Depression in Secondary Care. | Friedl N et al. | β | 2020 | β |
| Using the Personalized Advantage Index for individual treatment allocation to cognitive behavioral therapy (CBT) or a CBT with integrated exposure and emotion-focused elements (CBT-EE). | Friedl N et al. | β | 2020 | β |
| Vat polymerization-based bioprinting-process, materials, applications and regulatory challenges. | Ng WL et al. | β | 2020 | β |
| 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight. | Isreb A et al. | β | 2019 | β |
| A Fast Parameter Identification Framework for Personalized Pharmacokinetics. | Yang C et al. | β | 2019 | β |
| Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study. | Liu P et al. | β | 2019 | β |
| Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. | Tiwari S et al. | β | 2019 | β |
| A machine learning ensemble to predict treatment outcomes following an Internet intervention for depression. | Pearson R et al. | β | 2019 | β |
| Amalgamation of polyphenols and probiotics induce health promotion. | Banerjee A et al. | β | 2019 | β |
| Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders. | Pollak TA et al. | β | 2019 | β |
| Assessing heterogeneous effects and their determinants via estimation of potential outcomes. | Nilsson A et al. | β | 2019 | β |
| Association Between 6-Week Postdischarge Risk Classification and 12-Month Outcomes After Orthopedic Trauma. | Castillo RC et al. | β | 2019 | β |
| Can we wean patients with inflammatory arthritis from biological therapies? | Edwards CJ et al. | β | 2019 | β |
| Causability and explainability of artificial intelligence in medicine. | Holzinger A et al. | β | 2019 | β |
| Client-level predictors of treatment engagement, outcome and dropout: moving beyond demographics. | Youn SJ et al. | β | 2019 | β |
| Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome. | Windgassen S et al. | β | 2019 | β |
| Common themes and challenges in hemophilia care: a multinational perspective. | Stoffman J et al. | β | 2019 | β |
| Development of a general logistic model for disease risk prediction using multiple SNPs. | Long C et al. | β | 2019 | β |
| Diagnostic Optical Sequencing. | Korshoj LE et al. | β | 2019 | β |
| Differences in demographics and complementary and alternative medicine use between patients attending integrative kampo versus biomedical clinics in Japan. | Melby MK et al. | β | 2019 | β |
| Difficulties and challenges in the development of precision medicine. | Liu X et al. | β | 2019 | β |
| Estimating the quality of optimal treatment regimes. | Sies A et al. | β | 2019 | β |
| Evaluating the consistency of large-scale pharmacogenomic studies. | Rahman R et al. | β | 2019 | β |
| Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. | Farhan SMK et al. | β | 2019 | β |
| Fabrication and finite element analysis of stereolithographic 3D printed microneedles for transdermal delivery of model dyes across human skin in vitro. | Xenikakis I et al. | β | 2019 | β |
| Focusing personality assessment on the person: Modeling general, shared, and person specific processes in personality and psychopathology. | Wright AGC et al. | β | 2019 | β |
| For Whom Does Cognitively Based Compassion Training (CBCT) Work? An Analysis of Predictors and Moderators among African American Suicide Attempters. | Sun S et al. | β | 2019 | β |
| General functional connectivity: Shared features of resting-state and task fMRI drive reliable and heritable individual differences in functional brain networks. | Elliott ML et al. | β | 2019 | β |
| Genetic disorder prenatal diagnosis and pregnancy termination practices among high consanguinity population, Saudi Arabia. | AbdulAzeez S et al. | β | 2019 | β |
| Health risk prediction models incorporating personality data: Motivation, challenges, and illustration. | Chapman BP et al. | β | 2019 | β |
| Heterogeneity in the Co-occurrence of Substance Use and Posttraumatic Stress Disorder: A Latent Class Analysis Approach. | Contractor AA et al. | β | 2019 | β |
| Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles. | Singh A et al. | β | 2019 | β |
| Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure. | Cabrini G | β | 2019 | β |
| In Situ Sampling and Monitoring Cell-Free DNA of the Epstein-Barr Virus from Dermal Interstitial Fluid Using Wearable Microneedle Patches. | Yang B et al. | β | 2019 | β |
| Internet-delivered cognitive behavioural therapy for post-traumatic stress disorder: systematic review and meta-analysis. | Lewis C et al. | β | 2019 | β |
| Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'. | Wright S et al. | β | 2019 | β |
| Noninvasive Assessment of Exosome Pharmacokinetics In Vivo: A Review. | Kim DH et al. | β | 2019 | β |
| On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing. | El Aita I et al. | β | 2019 | β |
| Open trial of a personalized modular treatment for mood and anxiety. | Fisher AJ et al. | β | 2019 | β |
| Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors. | Cooper JM et al. | β | 2019 | β |
| Personalization in biomedical-informatics: Methodological considerations and recommendations. | Kaptein M | β | 2019 | β |
| Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary. | Richman S et al. | β | 2019 | β |
| Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline. | Miscio G et al. | β | 2019 | β |
| Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers. | Sa JK et al. | β | 2019 | β |
| Poly(vinyl alcohol) 3D printed tablets: The effect of polymer particle size on drug loading and process efficiency. | Saviano M et al. | β | 2019 | β |
| Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder. | Infanger S et al. | β | 2019 | β |
| Precision Medicine in Non Communicable Diseases. | Hasanzad M et al. | β | 2019 | β |
| Preparing healthcare delivery organizations for managing computable knowledge. | Adler-Milstein J et al. | β | 2019 | β |
| Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery. | Linares V et al. | β | 2019 | β |
| PSICA: Decision trees for probabilistic subgroup identification with categorical treatments. | Sysoev O et al. | β | 2019 | β |
| Robustifying Trial-Derived Optimal Treatment Rules for A Target Population. | Zhao YQ et al. | β | 2019 | β |
| Seconds-resolved pharmacokinetic measurements of the chemotherapeutic irinotecan <i>in situ</i> in the living body. | Idili A et al. | β | 2019 | β |
| Sequencing XMET genes to promote genotype-guided risk assessment and precision medicine. | Jin Y et al. | β | 2019 | β |
| Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening. | Lim SH et al. | β | 2019 | β |
| The concept of genome after one century of usage. | Cristescu ME | β | 2019 | β |
| The Pulse-Respiration Quotient: A Powerful but Untapped Parameter for Modern Studies About Human Physiology and Pathophysiology. | Scholkmann F et al. | β | 2019 | β |
| The Use of Deep Learning to Predict Stroke Patient Mortality. | Cheon S et al. | β | 2019 | β |
| Towards feedback-controlled nanomedicines for smart, adaptive delivery. | Jones SJ et al. | β | 2019 | β |
| Towards the Delivery of Precision Veterinary Cancer Medicine. | Katogiritis A et al. | β | 2019 | β |
| Wearable and flexible electronics for continuous molecular monitoring. | Yang Y et al. | β | 2019 | β |
| 3D printed UV light cured polydimethylsiloxane devices for drug delivery. | HollΓ€nder J et al. | β | 2018 | β |
| 3D Printing Pharmaceuticals: Drug Development to Frontline Care. | Trenfield SJ et al. | β | 2018 | β |
| 3D Printing Technology in Design of Pharmaceutical Products. | Ameeduzzafar et al. | β | 2018 | β |
| 3D Printing Technology in Drug Delivery: Recent Progress and Application. | Kotta S et al. | β | 2018 | β |
| A Blockwise Consistency Method for Parameter Estimation of Complex Models. | Shi R et al. | β | 2018 | β |
| Addressing Unmet Clinical Needs with 3D Printing Technologies. | Ghosh U et al. | β | 2018 | β |
| A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers. | Lin E et al. | β | 2018 | β |
| An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests. | Doubleday K et al. | β | 2018 | β |
| Analysis of outpatient HER2 testing in New York state using the statewide planning and research cooperative system. | Hefti E et al. | β | 2018 | β |
| AN ITALIAN SURVEY OF COMPLIANCE WITH MAJOR GUIDELINES FOR L-THYROXINE OF PRIMARY HYPOTHYROIDISM. | Vezzani S et al. | β | 2018 | β |
| Anthropometrics, Metabolic Syndrome, and Mortality Hazard. | Krakauer NY et al. | β | 2018 | β |
| A public health perspective on personalized periodontics. | Knight ET et al. | β | 2018 | β |
| A simulation study on estimating biomarker-treatment interaction effects in randomized trials with prognostic variables. | Haller B et al. | β | 2018 | β |
| A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy. | Sau S et al. | β | 2018 | β |
| Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development. | Bay-Jensen AC et al. | β | 2018 | β |
| Biomaterials-based 3D cell printing for next-generation therapeutics and diagnostics. | Jang J et al. | β | 2018 | β |
| Biopsychological and pathophysiological features of Cold-Heat subgroup of Sasang typology with Sasang Digestive Function Inventory, Sasang Personality Questionnaire and Body Mass Index. | Lee J et al. | β | 2018 | β |
| Calcium phosphate-based nanosystems for advanced targeted nanomedicine. | Degli Esposti L et al. | β | 2018 | β |
| Challenges and Approaches in Microbiome Research: From Fundamental to Applied. | Sergaki C et al. | β | 2018 | β |
| Cognitive and Interpersonal Vulnerabilities to Adolescent Depression: Classification of Risk Profiles for a Personalized Prevention Approach. | Hankin BL et al. | β | 2018 | β |
| Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial. | O'Dwyer JL et al. | β | 2018 | β |
| Diagnosis and management of metastatic neoplasms with unknown primary. | Bochtler T et al. | β | 2018 | β |
| Drug delivery systems for programmed and on-demand release. | Davoodi P et al. | β | 2018 | β |
| Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment. | Soares MO et al. | β | 2018 | β |
| Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making. | Chow N et al. | β | 2018 | β |
| Extracorporeal photopheresis and personalized medicine in the 21st century: The future's so bright! | Raval JS et al. | β | 2018 | β |
| Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels. | Crawford DC et al. | β | 2018 | β |
| Fridge: Focused fine-tuning of ridge regression for personalized predictions. | Hellton KH et al. | β | 2018 | β |
| From Vascular Smooth Muscle Cells to Folliculogenesis: What About Vasorin? | Bonnet AL et al. | β | 2018 | β |
| Genetics of personalized medicine: cancer and rare diseases. | Alves ITS et al. | β | 2018 | β |
| Highlights on the Application of Genomics and Bioinformatics in the Fight Against Infectious Diseases: Challenges and Opportunities in Africa. | Bah SY et al. | β | 2018 | β |
| Hospitalised cancer patients' perceptions of individualised nursing care in four European countries. | Suhonen R et al. | β | 2018 | β |
| How to customize a bona fide psychotherapy for generalized anxiety disorder? A two-arms, patient blinded, ABAB crossed-therapist randomized clinical implementation trial design [IMPLEMENT 2.0]. | FlΓΌckiger C et al. | β | 2018 | β |
| Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome. | Chen KS et al. | β | 2018 | β |
| Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules. | Butler EL et al. | β | 2018 | β |
| Individual treatment selection for patients with posttraumatic stress disorder. | Deisenhofer AK et al. | β | 2018 | β |
| Integration of sample preparation and analysis into an optofluidic chip for multi-target disease detection. | Meena GG et al. | β | 2018 | β |
| LIBERTI: A SMART study in plastic surgery. | Hibbard JC et al. | β | 2018 | β |
| Molecular basis of cystic fibrosis: from bench to bedside. | Dechecchi MC et al. | β | 2018 | β |
| Nanomedicine for neuroHIV/AIDS management. | Kaushik A et al. | β | 2018 | β |
| Natural Humic-Acid-Based Phototheranostic Agent. | Miao ZH et al. | β | 2018 | β |
| Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity. | BalΓ§a-Silva J et al. | β | 2018 | β |
| On the readiness of physicians for pharmacogenomics testing: an empirical assessment. | Amara N et al. | β | 2018 | β |
| Opportunities and obstacles for deep learning in biology and medicine. | Ching T et al. | β | 2018 | β |
| Organic Electronics for Point-of-Care Metabolite Monitoring. | Pappa AM et al. | β | 2018 | β |
| Patient and provider perspectives on the development of personalized medicine: a mixed-methods approach. | Puryear L et al. | β | 2018 | β |
| Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness. | Stegemann S | β | 2018 | β |
| Personalised treatment for cognitive dysfunction in individuals with schizophrenia spectrum disorders. | Medalia A et al. | β | 2018 | β |
| Personalized nanomedicine for CNS diseases. | Kaushik A et al. | β | 2018 | β |
| Personalized psychiatry: Promises and pitfalls. | Manchia M et al. | β | 2018 | β |
| Pharmacogenetics and cognitive symptoms in schizophrenia patients treated with antipsychotics. | Musil R et al. | β | 2018 | β |
| Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. | Lee JK et al. | β | 2018 | β |
| Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other Medicines. | Pregelj L et al. | β | 2018 | β |
| Prediction of Atypical Ductal Hyperplasia Upgrades Through a Machine Learning Approach to Reduce Unnecessary Surgical Excisions. | Harrington L et al. | β | 2018 | β |
| Randomized clinical trials and personalized medicine: A commentary on deaton and cartwright. | Schork NJ | β | 2018 | β |
| Recent updates and challenges on the regulation of precision medicine: The United States in perspective. | Chang LC et al. | β | 2018 | β |
| Representing a "revolution": how the popular press has portrayed personalized medicine. | Marcon AR et al. | β | 2018 | β |
| Testing for differentially expressed genetic pathways with single-subject N-of-1 data in the presence of inter-gene correlation. | Schissler AG et al. | β | 2018 | β |
| The Canadian Partnership for Tomorrow Project: a pan-Canadian platform for research on chronic disease prevention. | Dummer TJB et al. | β | 2018 | β |
| The future of drug development: the paradigm shift towards systems therapeutics. | Danhof M et al. | β | 2018 | β |
| The Impact of Novel Assessment Methodologies in Toxicology on Green Chemistry and Chemical Alternatives. | Rusyn I et al. | β | 2018 | β |
| The potential value of nanomedicine and novel oral dosage forms in the treatment of HIV. | Hobson JJ et al. | β | 2018 | β |
| Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease. | Kurt Z et al. | β | 2018 | β |
| Towards Personalized Rehabilitation for Gait Impairments in Parkinson's Disease. | Nonnekes J et al. | β | 2018 | β |
| Towards precision medicine; a new biomedical cosmology. | Vegter MW | β | 2018 | β |
| Treatment Selection in Depression. | Cohen ZD et al. | β | 2018 | β |
| Type D personality, stress, coping and performance on a novel sport task. | Borkoles E et al. | β | 2018 | β |
| Use of Patient-Specific Instrumentation (PSI) for glenoid component positioning in shoulder arthroplasty. A systematic review and meta-analysis. | Villatte G et al. | β | 2018 | β |
| Valvejet Technology for the Production of a Personalised Fixed Dose Combination of Ramipril and Glimepiride: an Investigative Study on the Stability of Ramipril. | Kollamaram G et al. | β | 2018 | β |
| VEGFA and VEGFR2 RNAscope determination in gastric cancer. | Tamma R et al. | β | 2018 | β |
| 3D printed drug delivery devices: perspectives and technical challenges. | Palo M et al. | β | 2017 | β |
| A Biomimetic Phosphatidylcholine-Terminated Monolayer Greatly Improves the In Vivo Performance of Electrochemical Aptamer-Based Sensors. | Li H et al. | β | 2017 | β |
| Academic, Foundation, and Industry Collaboration in Finding New Therapies. | Ramsey BW et al. | β | 2017 | β |
| Addressing the challenges of applying precision oncology. | Shin SH et al. | β | 2017 | β |
| Advancing Ultrasensitive Molecular and Cellular Analysis Methods to Speed and Simplify the Diagnosis of Disease. | Kelley SO | β | 2017 | β |
| A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials. | Niedzielski JS et al. | β | 2017 | β |
| Applying nanomedicine in maladaptive inflammation and angiogenesis. | Alaarg A et al. | β | 2017 | β |
| Applying systems biology to biomedical research and health care: a prΓ©cising definition of systems medicine. | Schleidgen S et al. | β | 2017 | β |
| A precision medicine approach to a patient with unresolved pain following orthopedic surgery: a case report. | Gazzaniga D et al. | β | 2017 | β |
| A Research Agenda for Communication Scholars in the Precision Medicine Era. | Scherr CL et al. | β | 2017 | β |
| Are the Origins of Precision Medicine Found in the Corpus Hippocraticum? | Konstantinidou MK et al. | β | 2017 | β |
| Artificial Nose Technology: Status and Prospects in Diagnostics. | Fitzgerald JE et al. | β | 2017 | β |
| A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references. | Fukuda T et al. | β | 2017 | β |
| Assessing the readiness of precision medicine interoperabilty: An exploratory study of the National Institutes of Health genetic testing registry. | Ronquillo JG et al. | β | 2017 | β |
| Beyond disease susceptibility-Leveraging genome-wide association studies for new insights into complex disease biology. | Lee JC | β | 2017 | β |
| Breaking Down the Barriers to Precision Cancer Nanomedicine. | von Roemeling C et al. | β | 2017 | β |
| Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer. | Borchiellini D et al. | β | 2017 | β |
| Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. | Polite BN et al. | β | 2017 | β |
| Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. | Polite BN et al. | β | 2017 | β |
| Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. | Polite BN et al. | β | 2017 | β |
| Common Factors in Pediatric Psychiatry: A Review of Essential and Adjunctive Mechanisms of Treatment Outcome. | De Nadai AS et al. | β | 2017 | β |
| Comparing Four Methods for Estimating Tree-Based Treatment Regimes. | Sies A et al. | β | 2017 | β |
| Comprehensive benchmarking of SNV callers for highly admixed tumor data. | Bohnert R et al. | β | 2017 | β |
| Cutting Edge Methods for Non-Invasive Disease Diagnosis Using E-Tongue and E-Nose Devices. | Fitzgerald J et al. | β | 2017 | β |
| Deep into the Brain: Artificial Intelligence in Stroke Imaging. | Lee EJ et al. | β | 2017 | β |
| Determining the Optimal Neonatal Care for Preterm Infants in the Era of Personalized Medicine. | Lorch SA | β | 2017 | β |
| Development and initial implementation of the Dynamic Assessment Treatment Algorithm (DATA). | Fernandez KC et al. | β | 2017 | β |
| Discovery and Clinical Decision Support for Personalized Healthcare. | Yoon J et al. | β | 2017 | β |
| Drug discovery and development: Role of basic biological research. | Mohs RC et al. | β | 2017 | β |
| Electron Transfer Mediated by Surface-Tethered Redox Groups in Nanofluidic Devices. | Steentjes T et al. | β | 2017 | β |
| Embracing the unknown: disentangling the complexities of the soil microbiome. | Fierer N | β | 2017 | β |
| Enabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop. | Koo KM et al. | β | 2017 | β |
| Evaluating quality of life in epilepsy: The role of screening for adverse drug effects, depression, and anxiety. | Micoulaud-Franchi JA et al. | β | 2017 | β |
| Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical Trials. | Wallach JD et al. | β | 2017 | β |
| Evaluation of Podoplanin Expression in Hepatocellular Carcinoma Using RNAscope and Immunohistochemistry - A Preliminary Report. | Cioca A et al. | β | 2017 | β |
| Evaluation of the precision of contrast sensitivity function assessment on a tablet device. | Dorr M et al. | β | 2017 | β |
| Factors of primary and secondary sulfonylurea failure in type 2 diabetic subjects. | Wang H et al. | β | 2017 | β |
| Functional feature construction for individualized treatment regimes. | Laber EB et al. | β | 2017 | β |
| Gastrointestinal Organoids: Understanding the Molecular Basis of the Host-Microbe Interface. | Hill DR et al. | β | 2017 | β |
| Greedy outcome weighted tree learning of optimal personalized treatment rules. | Zhu R et al. | β | 2017 | β |
| Harnessing the Therapist Effect in Patient-Centered Mental Health Care Decision Making. | Boswell JF et al. | β | 2017 | β |
| How are you feeling?: A personalized methodology for predicting mental states from temporally observable physical and behavioral information. | Tuarob S et al. | β | 2017 | β |
| How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings From an Expert Round Table Discussion. | Gordon A et al. | β | 2017 | β |
| How to Study Chronic Diseases-Implications of the Convention on the Rights of Persons with Disabilities for Research Designs. | von Peter S et al. | β | 2017 | β |
| Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. | van der Wouden CH et al. | β | 2017 | β |
| Individualized versus conventional ovarian stimulation for inΒ vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. | Nyboe Andersen A et al. | β | 2017 | β |
| Interdisciplinary approach towards a systems medicine toolbox using the example of inflammatory diseases. | Bauer CR et al. | β | 2017 | β |
| Internet-based guided self-help for posttraumatic stress disorder (PTSD): Randomized controlled trial. | Lewis CE et al. | β | 2017 | β |
| Investigation of copy number variation in subjects with major depression based on whole-genome sequencing data. | Yu C et al. | β | 2017 | β |
| Knowing your genes: does this impact behaviour change? | O'Donovan CB et al. | β | 2017 | β |
| Lessons Learned From Past Gene-Environment Interaction Successes. | Ritz BR et al. | β | 2017 | β |
| Lifestyle intervention to prevent obesity during pregnancy: Implications and recommendations for research and implementation. | Hill B et al. | β | 2017 | β |
| Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy. | Lee YC et al. | β | 2017 | β |
| Mapping Neighborhood Health Geomarkers To Clinical Care Decisions To Promote Equity In Child Health. | Beck AF et al. | β | 2017 | β |
| Microphysiological Human Brain and Neural Systems-on-a-Chip: Potential Alternatives to Small Animal Models and Emerging Platforms for Drug Discovery and Personalized Medicine. | Haring AP et al. | β | 2017 | β |
| miR-10b is a prognostic marker in clear cell renal cell carcinoma. | Khella HWZ et al. | β | 2017 | β |
| Model-Based Therapy Planning Allows Prediction of Haemodynamic Outcome after Aortic Valve Replacement. | Kelm M et al. | β | 2017 | β |
| Moving to a culture of health. | Denham SA | β | 2017 | β |
| N-of-1 Design and Its Applications to Personalized Treatment Studies. | Xie T et al. | β | 2017 | β |
| On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology. | Rao RT et al. | β | 2017 | β |
| Overview of the BioBank Japan Project: Study design and profile. | Nagai A et al. | β | 2017 | β |
| Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer. | Kuderer NM et al. | β | 2017 | β |
| Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients. | Luo G et al. | β | 2017 | β |
| Peptide Nucleic Acid-Based Biosensors for Cancer Diagnosis. | D'Agata R et al. | β | 2017 | β |
| Personalized genetics of the cholinergic blockade of neuroinflammation. | Simchovitz A et al. | β | 2017 | β |
| Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids. | Raghavan S et al. | β | 2017 | β |
| Personalized medicine could transform healthcare. | Mathur S et al. | β | 2017 | β |
| Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects. | Shoaib M et al. | β | 2017 | β |
| Personalized plasma-based medicine to treat age-related diseases. | Anitua E et al. | β | 2017 | β |
| Photoacoustic signal characterization of cancer treatment response: Correlation with changes in tumor oxygenation. | Hysi E et al. | β | 2017 | β |
| Population Pharmacokinetics of Intravenous Methotrexate in Patients with Hematological Malignancies: Utilization of Routine Clinical Monitoring Parameters. | Nader A et al. | β | 2017 | β |
| Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. | Hellings PW et al. | β | 2017 | β |
| Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not? | Kranzler HR et al. | β | 2017 | β |
| Precision wildlife medicine: applications of the human-centred precision medicine revolution to species conservation. | Whilde J et al. | β | 2017 | β |
| Prediction models for exacerbations in patients with COPD. | Guerra B et al. | β | 2017 | β |
| Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review. | Pirone C et al. | β | 2017 | β |
| Principles of precision medicine in stroke. | Hinman JD et al. | β | 2017 | β |
| Quantitative diagnosis of breast tumors by characterization of viscoelastic behavior of healthy breast tissue. | Madani N et al. | β | 2017 | β |
| (Re) Making the Procrustean Bed? Standardization and Customization as Competing Logics in Healthcare. | Mannion R et al. | β | 2017 | β |
| Research and Discovery Science and the Future of Dental Education and Practice. | Polverini PJ et al. | β | 2017 | β |
| Rethinking cancer nanotheranostics. | Chen H et al. | β | 2017 | β |
| Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension. | McNulty H et al. | β | 2017 | β |
| Role of stem cell-derived exosomes in cancer. | Wu J et al. | β | 2017 | β |
| Saving costs in cancer patient management through molecular imaging. | von Gall C et al. | β | 2017 | β |
| Sex differences in stress effects on emotional learning. | Merz CJ et al. | β | 2017 | β |
| Single-nucleotide variant proportion in genes: a new concept to explore major depression based on DNA sequencing data. | Yu C et al. | β | 2017 | β |
| SNOMED2HL7: A tool to normalize and bind SNOMED CT concepts to the HL7 Reference Information Model. | Perez-Rey D et al. | β | 2017 | β |
| Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics. | GroΓerueschkamp F et al. | β | 2017 | β |
| Spatiotemporal genomic architecture informs precision oncology in glioblastoma. | Lee JK et al. | β | 2017 | β |
| Standardized Care Versus Precision Medicine in the Perioperative Setting: Can Point-of-Care Testing Help Bridge the Gap? | Iravani M et al. | β | 2017 | β |
| Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems. | Sahlgren C et al. | β | 2017 | β |
| The history and development of N-of-1 trials. | Mirza RD et al. | β | 2017 | β |
| The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics. | Amin AM et al. | β | 2017 | β |
| The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges. | McCue ME et al. | β | 2017 | β |
| The use of behavioural genetics in the criminal justice system: A disability & human rights perspective. | O'Mahony C et al. | β | 2017 | β |
| [Toward dynamic informed consent]. | StoeklΓ© HC et al. | β | 2017 | β |
| Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams. | Shameer K et al. | β | 2017 | β |
| Utilizing Forced Vital Capacity to Predict Low Lung Compliance and Select Intraoperative Tidal Volume During Thoracic Surgery. | Hoftman N et al. | β | 2017 | β |
| UV-crosslinkable and thermo-responsive chitosan hybrid hydrogel for NIR-triggered localized on-demand drug delivery. | Wang L et al. | β | 2017 | β |
| What is precision medicine? | KΓΆnig IR et al. | β | 2017 | β |
| Whole-genome single nucleotide variant distribution on genomic regions and its relationship to major depression. | Yu C et al. | β | 2017 | β |
| Young Adults' Belief in Genetic Determinism, and Knowledge and Attitudes towards Modern Genetics and Genomics: The PUGGS Questionnaire. | Carver RB et al. | β | 2017 | β |
| A crowdsourcing workflow for extracting chemical-induced disease relations from free text. | Li TS et al. | β | 2016 | β |
| Active Clinical Trials for Personalized Medicine. | Minsker S et al. | β | 2016 | β |
| Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. | Sadia M et al. | β | 2016 | β |
| A Modular Repository-based Infrastructure for Simulation Model Storage and Execution Support in the Context of <i>In Silico</i> Oncology and <i>In Silico</i> Medicine. | Christodoulou NA et al. | β | 2016 | β |
| A new neuroinformatics approach to personalized medicine in neurology: The Virtual Brain. | Falcon MI et al. | β | 2016 | β |
| Annual Research Review: Building a science of personalized intervention for youth mental health. | Ng MY et al. | β | 2016 | β |
| An optimal stratified Simon two-stage design. | Parashar D et al. | β | 2016 | β |
| A Predictive Model for Personalized Therapeutic Interventions in Non-small Cell Lung Cancer. | Kureshi N et al. | β | 2016 | β |
| A ratiometric theranostic probe for tumor targeting therapy and self-therapeutic monitoring. | Li SY et al. | β | 2016 | β |
| "A rising tide lifts all boats": establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease. | McGowan ML et al. | β | 2016 | β |
| BDNF Val66Met Polymorphism as a Moderator of Exercise Enhancement of Smoking Cessation Treatment in Anxiety Vulnerable Adults. | Smits JA et al. | β | 2016 | β |
| Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine. | Blasimme A et al. | β | 2016 | β |
| Blood transcriptomics and metabolomics for personalized medicine. | Li S et al. | β | 2016 | β |
| Building towards precision medicine: empowering medical professionals for the next revolution. | McGrath S et al. | β | 2016 | β |
| Can metabotyping help deliver the promise of personalised nutrition? | O'Donovan CB et al. | β | 2016 | β |
| CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy. | Rostoker R et al. | β | 2016 | β |
| Clinical Decision Support: a 25 Year Retrospective and a 25 Year Vision. | Middleton B et al. | β | 2016 | β |
| Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis. | Furukawa TA et al. | β | 2016 | β |
| Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction. | Chu P et al. | β | 2016 | β |
| Data-driven health management: reasoning about personally generated data in diabetes with information technologies. | Mamykina L et al. | β | 2016 | β |
| Dual-responsive immunosensor that combines colorimetric recognition and electrochemical response for ultrasensitive detection of cancer biomarkers. | Hong W et al. | β | 2016 | β |
| Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume. | Fillman SG et al. | β | 2016 | β |
| Elucidation of Taste- and Odor-Producing Bacteria and Toxigenic Cyanobacteria in a Midwestern Drinking Water Supply Reservoir by Shotgun Metagenomic Analysis. | Otten TG et al. | β | 2016 | β |
| Enhancement of Pathologist's Routine Practice: Reuse of DNA Extracted from Immunostained Formalin-fixed Paraffin-embedded (FFPE) Slides in Downstream Molecular Analysis of Cancer. | Al-Attas A et al. | β | 2016 | β |
| Ensuring sustainability of software tools and services by cooperation with a research infrastructure. | Kuchinke W et al. | β | 2016 | β |
| Epigenome-based personalized medicine in human cancer. | Yan W et al. | β | 2016 | β |
| Evolving to Personalized Medicine for Type 2 Diabetes. | Reddy SS | β | 2016 | β |
| Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. | Hadla M et al. | β | 2016 | β |
| Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine. | Trifonova O et al. | β | 2016 | β |
| Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy? | Maddaloni E et al. | β | 2016 | β |
| Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells. | Yan Y et al. | β | 2016 | β |
| Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. | Molina D et al. | β | 2016 | β |
| High-Resolution Metabolomics: Review of the Field and Implications for Nursing Science and the Study of Preterm Birth. | Li S et al. | β | 2016 | β |
| How close are we to individualized medicine for Parkinson's disease? | Kim HJ et al. | β | 2016 | β |
| Hypertension and aging. | Buford TW | β | 2016 | β |
| ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer. | Sun H et al. | β | 2016 | β |
| Learning Optimal Individualized Treatment Rules from Electronic Health Record Data. | Wang Y et al. | β | 2016 | β |
| MicroRNA-Based Biomarkers in Pain. | Ramanathan S et al. | β | 2016 | β |
| Milk Production and Fertility in Cattle. | Berry DP et al. | β | 2016 | β |
| Minimum information required for a DMET experiment reporting. | Kumuthini J et al. | β | 2016 | β |
| Molecular driver alterations and their clinical relevance in cancer of unknown primary site. | LΓΆffler H et al. | β | 2016 | β |
| Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma? | De Ferrari L et al. | β | 2016 | β |
| Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier. | Tan A et al. | β | 2016 | β |
| Navigating pleiotropy in precision medicine: pharmacogenes from trauma to behavioral health. | Oberg V et al. | β | 2016 | β |
| Neurocognitive rehabilitation for addiction medicine: From neurophysiological markers to cognitive rehabilitation and relapse prevention. | Campanella S | β | 2016 | β |
| Nurses' characteristics and organisational factors associated with their assessments of individualised care in care institutions for older people. | RodrΓguez-MartΓn B et al. | β | 2016 | β |
| On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy). | Candia M et al. | β | 2016 | β |
| Optimal radiotherapy dose schedules under parametric uncertainty. | Badri H et al. | β | 2016 | β |
| Personalized medicine and blood disorders. | Zhang L | β | 2016 | β |
| Personalized medicine and treatment approaches in hypertension: current perspectives. | Byrd JB | β | 2016 | β |
| Personalized medicine in rheumatology. | KΕak A et al. | β | 2016 | β |
| Personalized medicine: the enabling role of nanotechnology. | Herrmann IK et al. | β | 2016 | β |
| Personalized third-trimester fetal growth evaluation: comparisons of individualized growth assessment, percentile line and conditional probability methods. | Deter RL et al. | β | 2016 | β |
| PGWD: Integrating Personal Genome for Warfarin Dosing. | Pan Y et al. | β | 2016 | β |
| Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. | Hartmanshenn C et al. | β | 2016 | β |
| Population Pharmacokinetics of Fentanyl in the Critically Ill. | Choi L et al. | β | 2016 | β |
| Population Phylogenomics of Extraintestinal Pathogenic Escherichia coli. | Tourret J et al. | β | 2016 | β |
| Precision medical communication to optimize stakeholder information exchange: a '4M-Quadrant' approach. | Ashkenazy R | β | 2016 | β |
| Precision medicine, genomics and drug discovery. | Cardon LR et al. | β | 2016 | β |
| Printed Drug-Delivery Systems for Improved Patient Treatment. | Sandler N et al. | β | 2016 | β |
| Quantitative Systems Pharmacology: A Framework for Context. | Androulakis IP | β | 2016 | β |
| Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses. | Wallach JD et al. | β | 2016 | β |
| Simulation of Trauma Incidents : Modelling the Evolution of Patients and Resources. | Borri A et al. | β | 2016 | β |
| Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells. | GΓΆse M et al. | β | 2016 | β |
| Study design in high-dimensional classification analysis. | SΓ‘nchez BN et al. | β | 2016 | β |
| <sup>64</sup>Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor. | Kruziki MA et al. | β | 2016 | β |
| Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach. | Romashov LV et al. | β | 2016 | β |
| Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events. | Yu Y et al. | β | 2016 | β |
| Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease. | Zmora N et al. | β | 2016 | β |
| The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. | Brixner D et al. | β | 2016 | β |
| The impact of <i>MTHFR</i> 677CβββT risk knowledge on changes in folate intake: findings from the Food4Me study. | O'Donovan CB et al. | β | 2016 | β |
| The path to personalized vascular therapy - We are closer than we think. | Forbes TL | β | 2016 | β |
| The Person in a State of Sickness. | Γrnason V et al. | β | 2016 | β |
| The safety of monoclonal antibodies in asthma. | Passalacqua G et al. | β | 2016 | β |
| Toward a Personalized Science of Emotion Regulation. | DorΓ© BP et al. | β | 2016 | β |
| Translation in Data Mining to Advance Personalized Medicine for Health Equity. | Estape ES et al. | β | 2016 | β |
| Turkish Ministry of Health, 2<sup>nd</sup> Turkish Medical General Assembly Clinical Oncology Study Group Report. | Γzmen V et al. | β | 2016 | β |
| Update on immunotherapy for the treatment of asthma. | Canonica GW et al. | β | 2016 | β |
| Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy. | Laber EB et al. | β | 2016 | β |
| What Factors Are Associated with Positive Effects of Dog Ownership in Families with Children with Autism Spectrum Disorder? The Development of the Lincoln Autism Pet Dog Impact Scale. | Hall SS et al. | β | 2016 | β |
| 3D Printed Anatomical Nerve Regeneration Pathways. | Johnson BN et al. | β | 2015 | β |
| 8th Georg Rajka International Symposium on Atopic Dermatitis: meeting report. | George SM et al. | β | 2015 | β |
| Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers. | Meshkin B et al. | β | 2015 | β |
| Advancing a Vision for Regulatory Science Training. | Adamo JE et al. | β | 2015 | β |
| A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens. | Jacobson RS et al. | β | 2015 | β |
| A flexible-dose dispenser for immediate and extended release 3D printed tablets. | Pietrzak K et al. | β | 2015 | β |
| A Framework for Enhancing the Value of Research for Dissemination and Implementation. | Neta G et al. | β | 2015 | β |
| AIT (allergen immunotherapy): a model for the "precision medicine". | Passalacqua G et al. | β | 2015 | β |
| Allergen Immunotherapy (AIT): a prototype of Precision Medicine. | Canonica GW et al. | β | 2015 | β |
| A multilevel pan-cancer map links gene mutations to cancer hallmarks. | Knijnenburg TA et al. | β | 2015 | β |
| An analysis of original research contributions toward FDA-approved drugs. | Patridge EV et al. | β | 2015 | β |
| An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood. | Li S et al. | β | 2015 | β |
| Artocarpus altilis CG-901 alters critical nodes in the JH1-kinase domain of Janus kinase 2 affecting upstream JAK/STAT3 signaling. | Nash O et al. | β | 2015 | β |
| Assessment of a tumor bank: a thirty years experience of the University of Siena (Italy). | Corso G et al. | β | 2015 | β |
| A systematic approach to subgroup analyses in a smoking cessation trial. | Westover AN et al. | β | 2015 | β |
| Behavior matters: the relevance, impact, and reach of behavioral medicine. | Wilson DK | β | 2015 | β |
| Bench-to-Bedside; Clinical and Translational Research; Personalized Medicine; Precision Medicine-What's in a Name? | Feldman AM | β | 2015 | β |
| Biomarkers in reproductive medicine: the quest for new answers. | Simon C et al. | β | 2015 | β |
| BioMiner: Paving the Way for Personalized Medicine. | Bauer C et al. | β | 2015 | β |
| Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine. | Thomas DM et al. | β | 2015 | β |
| Centennial inventory: the changing face of orthodontics. | Ghafari JG | β | 2015 | β |
| Challenges and Opportunities for Exploring Patient-Level Data. | Lopes P et al. | β | 2015 | β |
| Clinical next-generation sequencing in patients with non-small cell lung cancer. | Hagemann IS et al. | β | 2015 | β |
| Clinical phenotypes of asthma should link up with disease mechanisms. | Chung KF et al. | β | 2015 | β |
| Computational modeling of neurostimulation in brain diseases. | Wang Y et al. | β | 2015 | β |
| Confirmatory test of two factors and four subtypes of bipolar disorder based on lifetime psychiatric co-morbidity. | Monahan PO et al. | β | 2015 | β |
| Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology. | Garfeld S et al. | β | 2015 | β |
| CUSTOMIZED TRAINING WITH AN APPLICATION TO MASS SPECTROMETRIC IMAGING OF CANCER TISSUE. | Powers S et al. | β | 2015 | β |
| CYP2D6 phenotype-specific codeine population pharmacokinetics. | Linares OA et al. | β | 2015 | β |
| Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder. | Setyawan J et al. | β | 2015 | β |
| Development and Validation of an Immuno-PET Tracer as a Companion Diagnostic Agent for Antibody-Drug Conjugate Therapy to Target the CA6 Epitope. | Ilovich O et al. | β | 2015 | β |
| Editorial: Rethinking the definition of diabetes for precision medicine. | Ahima RS | β | 2015 | β |
| Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. | Wu IC et al. | β | 2015 | β |
| EPMA position paper in cancer: current overview and future perspectives. | Grech G et al. | β | 2015 | β |
| ESR Position Paper on Imaging Biobanks. | European Society of Radiology (ESR) | β | 2015 | β |
| Ethics and genomic medicine, how to navigate decisions in surgical oncology. | Devon KM et al. | β | 2015 | β |
| Examining Differences in Patterns of Sensory and Motor Recovery After Stroke With Robotics. | Semrau JA et al. | β | 2015 | β |
| Friends, social networks, and progressive chronic kidney disease. | McClellan WM et al. | β | 2015 | β |
| Functional maintenance of differentiated embryoid bodies in microfluidic systems: a platform for personalized medicine. | Guven S et al. | β | 2015 | β |
| Fundamentals and application of magnetic particles in cell isolation and enrichment: a review. | Plouffe BD et al. | β | 2015 | β |
| Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes. | Johansen Taber KA et al. | β | 2015 | β |
| "Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing. | Trinidad SB et al. | β | 2015 | β |
| Governing the research-care divide in clinical biobanking: Dutch perspectives. | Boeckhout M et al. | β | 2015 | β |
| Improvement of dissolution rate of indomethacin by inkjet printing. | WickstrΓΆm H et al. | β | 2015 | β |
| Individualizing prophylaxis in hemophilia: a review. | Petrini P et al. | β | 2015 | β |
| Integrative network modeling approaches to personalized cancer medicine. | Kidd BA et al. | β | 2015 | β |
| Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome. | Yip LY et al. | β | 2015 | β |
| iqLearn: Interactive Q-Learning in R. | Linn KA et al. | β | 2015 | β |
| Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear. | Mina MJ et al. | β | 2015 | β |
| Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example. | Hien DA et al. | β | 2015 | β |
| Methods for biological data integration: perspectives and challenges. | GligorijeviΔ V et al. | β | 2015 | β |
| Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity. | Masica DL et al. | β | 2015 | β |
| Molecular imaging in the era of personalized medicine. | Jung KH et al. | β | 2015 | β |
| Mortality Risk Prediction: Can Comorbidity Indices Be Improved With Psychosocial Data? | Chapman BP et al. | β | 2015 | β |
| Nanotoxicology: advances and pitfalls in research methodology. | Azhdarzadeh M et al. | β | 2015 | β |
| Need for gender-specific pre-analytical testing: the dark side of the moon in laboratory testing. | Franconi F et al. | β | 2015 | β |
| Needs Assessment for Research Use of High-Throughput Sequencing at a Large Academic Medical Center. | Geskin A et al. | β | 2015 | β |
| Next revolution in molecular theranostics: personalized medicine for urologic cancers. | Aoun F et al. | β | 2015 | β |
| Novel immunotherapies for hematologic malignancies. | Nelson MH et al. | β | 2015 | β |
| On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring. | Sanavio B et al. | β | 2015 | β |
| Personalized biochemistry and biophysics. | Kroncke BM et al. | β | 2015 | β |
| Personalized medicine: its implications and its impact on patents. | Schneider D et al. | β | 2015 | β |
| PGWD: integrating personal genome for warfarin dosing. | Pan Y et al. | β | 2015 | β |
| Phage-mediated counting by the naked eye of miRNA molecules at attomolar concentrations in a Petri dish. | Zhou X et al. | β | 2015 | β |
| Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas. | Dorfman EH et al. | β | 2015 | β |
| Polygenic risk for externalizing disorders: Gene-by-development and gene-by-environment effects in adolescents and young adults. | Salvatore JE et al. | β | 2015 | β |
| Predicting Optimal Outcomes in Cognitive Therapy or Interpersonal Psychotherapy for Depressed Individuals Using the Personalized Advantage Index Approach. | Huibers MJ et al. | β | 2015 | β |
| Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. | Dunnenberger HM et al. | β | 2015 | β |
| Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest. | Friesen CA et al. | β | 2015 | β |
| Primun non nocere, polypharmacy and pharmacogenetics. | Isidoro-GarcΓa M et al. | β | 2015 | β |
| Printing Tablets with Fully Customizable Release Profiles for Personalized Medicine. | Sun Y et al. | β | 2015 | β |
| Promising waste: biobanking, embryo research, and infrastructures of ethical efficiency. | Hurlbut JB | β | 2015 | β |
| Quantitative analysis of drug-induced complement-mediated cytotoxic effect on single tumor cells using atomic force microscopy and fluorescence microscopy. | Li M et al. | β | 2015 | β |
| Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. | Raunig DL et al. | β | 2015 | β |
| Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation. | Prasanna PG et al. | β | 2015 | β |
| Research Domain Criteria: toward future psychiatric nosologies. | Cuthbert BN | β | 2015 | β |
| Scoping review of patient- and family-oriented outcomes and measures for chronic pediatric disease. | Khangura SD et al. | β | 2015 | β |
| Sharing and Reuse of Sensitive Data and Samples: Supporting Researchers in Identifying Ethical and Legal Requirements. | Sariyar M et al. | β | 2015 | β |
| Status and Prospects of Aptamers as Drug Components. | Mattice CM et al. | β | 2015 | β |
| Subgroup Identification in Personalized Treatment of Alcohol Dependence. | Hou J et al. | β | 2015 | β |
| The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability. | Odeh H et al. | β | 2015 | β |
| The future of research in female pelvic medicine. | Chao J et al. | β | 2015 | β |
| The Genotype-Tissue Expression (GTEx) Project: Linking Clinical Data with Molecular Analysis to Advance Personalized Medicine. | Keen JC et al. | β | 2015 | β |
| The mathematical limits of genetic prediction for complex chronic disease. | Keyes KM et al. | β | 2015 | β |
| The next generation of smart gold nanobeacons: nanotheranostics is ready for prime time. | Conde J et al. | β | 2015 | β |
| The principles of whole-cell modeling. | Karr JR et al. | β | 2015 | β |
| The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies. | Barry WT et al. | β | 2015 | β |
| Toward a science of learning systems: a research agenda for the high-functioning Learning Health System. | Friedman C et al. | β | 2015 | β |
| Translating personalized genomic medicine into clinical practice: evidence, values, and health policy. | Bombard Y | β | 2015 | β |
| Tree-based methods for individualized treatment regimes. | Laber EB et al. | β | 2015 | β |
| Triggerable Degradation of Polyurethanes for Tissue Engineering Applications. | Xu C et al. | β | 2015 | β |
| Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns. | Ostergren JE et al. | β | 2015 | β |
| Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. | Ko TM et al. | β | 2015 | β |
| Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications. | Sajic T et al. | β | 2015 | β |
| Whole-genome sequencing targets drug-resistant bacterial infections. | Punina NV et al. | β | 2015 | β |
| Accounting for population variation in targeted proteomics. | Fujimoto GM et al. | β | 2014 | β |
| A control systems engineering approach for adaptive behavioral interventions: illustration with a fibromyalgia intervention. | Deshpande S et al. | β | 2014 | β |
| Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma. | Moore HB et al. | β | 2014 | β |
| Affinity biosensors for tumor-marker analysis. | Palchetti I | β | 2014 | β |
| Alcohol use disorder clinical course research: informing clinicians' treatment planning now and in the future. | Maisto SA et al. | β | 2014 | β |
| Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics. | Yang HC et al. | β | 2014 | β |
| A targeted approach to cancer imaging and therapy. | Li C | β | 2014 | β |
| A taste of individualized medicine: physicians' reactions to automated genetic interpretations. | LΓ¦rum H et al. | β | 2014 | β |
| Beyond information retrieval and electronic health record use: competencies in clinical informatics for medical education. | Hersh WR et al. | β | 2014 | β |
| Biobanks and personalized medicine. | Olson JE et al. | β | 2014 | β |
| Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers. | Schink JC et al. | β | 2014 | β |
| Biorepository regulatory frameworks: building parallel resources that both promote scientific investigation and protect human subjects. | Marko-Varga G et al. | β | 2014 | β |
| Bold goals for health-system pharmacy: Perspectives of an experienced practice leader. | Stevenson JG | β | 2014 | β |
| Buyang huanwu decoction for healthcare: evidence-based theoretical interpretations of treating different diseases with the same method and target of vascularity. | Li JH et al. | β | 2014 | β |
| Characteristics associated with informed consent for genetic studies in the ACCORD trial. | Simons-Morton DG et al. | β | 2014 | β |
| Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. | Theek B et al. | β | 2014 | β |
| Clinical phenotype network: the underlying mechanism for personalized diagnosis and treatment of traditional Chinese medicine. | Zhou X et al. | β | 2014 | β |
| Continuous monitoring of Naproxen by a cytochrome P450-based electrochemical sensor. | Baj-Rossi C et al. | β | 2014 | β |
| Convergent Lines of Descent: Symptoms, Patterns, Constellations, and the Emergent Interface of Systems Biology and Chinese Medicine. | Scheid V | β | 2014 | β |
| Creating a pipeline of talent for informatics: STEM initiative for high school students in computer science, biology, and biomedical informatics. | Dutta-Moscato J et al. | β | 2014 | β |
| Defining 'medical necessity' in an age of personalised medicine: A view from Canada. | Caulfield T et al. | β | 2014 | β |
| Defining phenotypes in asthma: a step towards personalized medicine. | Chung KF | β | 2014 | β |
| Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects. | Chistiakov DA et al. | β | 2014 | β |
| Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. | Rasmussen-Torvik LJ et al. | β | 2014 | β |
| Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms. | Attili F et al. | β | 2014 | β |
| DTC-and-Me: Patient, Provider, Proteins and Regulators. | Steele FR et al. | β | 2014 | β |
| Dynamic treatment regimes: technical challenges and applications. | Laber EB et al. | β | 2014 | β |
| Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease. | Huesgen PF et al. | β | 2014 | β |
| Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data. | Laurenson JP et al. | β | 2014 | β |
| Examining moderation analyses in propensity score methods: application to depression and substance use. | Green KM et al. | β | 2014 | β |
| Genotype-based prevention of psychosis onset and schizophrenia: a personalized approach in a target population. | Taneri B et al. | β | 2014 | β |
| Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas. | Bourkoula E et al. | β | 2014 | β |
| Has catechol-O-methyltransferase genotype (Val158Met) an influence on endocrine, sympathetic nervous and humoral immune systems in women with fibromyalgia syndrome? | FernΓ‘ndez-de-las-PeΓ±as C et al. | β | 2014 | β |
| High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform. | Lee DW et al. | β | 2014 | β |
| Housing code violation density associated with emergency department and hospital use by children with asthma. | Beck AF et al. | β | 2014 | β |
| Incorporating biopsychosocial characteristics into personalized healthcare: a clinical approach. | Evers AW et al. | β | 2014 | β |
| Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine. | McGowan ML et al. | β | 2014 | β |
| Integrating pharmacogenetic information and clinical decision support into the electronic health record. | Goldspiel BR et al. | β | 2014 | β |
| Kin-Driver: a database of driver mutations in protein kinases. | Simonetti FL et al. | β | 2014 | β |
| Legal aspects of biobanking as key issues for personalized medicine and translational exploitation. | Minssen T et al. | β | 2014 | β |
| Managing customization in health care: a framework derived from the services sector literature. | Minvielle E et al. | β | 2014 | β |
| MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft. | Fu P et al. | β | 2014 | β |
| MicroRNAs as non-invasive biomarkers of heart transplant rejection. | Duong Van Huyen JP et al. | β | 2014 | β |
| Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development. | Yoo SS et al. | β | 2014 | β |
| Molecular diagnostics clinical utility strategy: a six-part framework. | Frueh FW et al. | β | 2014 | β |
| Molecularly targeted cancer therapy: some lessons from the past decade. | Huang M et al. | β | 2014 | β |
| Multicenter ALK testing in non-small-cell lung cancer: results of a round robin test. | von Laffert M et al. | β | 2014 | β |
| Multidisciplinary efforts driving translational theranostics. | Hu TY | β | 2014 | β |
| Nanoscale distribution of CD20 on B-cell lymphoma tumour cells and its potential role in the clinical efficacy of rituximab. | Li M et al. | β | 2014 | β |
| Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics. | Pant S et al. | β | 2014 | β |
| Omics-based nanomedicine: the future of personalized oncology. | Rosenblum D et al. | β | 2014 | β |
| Opportunities and challenges provided by cloud repositories for bioinformatics-enabled drug discovery. | DalpΓ© G et al. | β | 2014 | β |
| Personalised medicine, disease prevention, and the inverse care law: more harm than benefit? | James JE | β | 2014 | β |
| Personality-informed interventions for healthy aging: conclusions from a National Institute on Aging work group. | Chapman BP et al. | β | 2014 | β |
| Personalized medicine, availability, and group disparity: an inquiry into how physicians perceive and rate the elements and barriers of personalized medicine. | Petersen KE et al. | β | 2014 | β |
| Personalized medicine in oncology: ethical implications for the delivery of healthcare. | Egalite N et al. | β | 2014 | β |
| Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness. | Linares OA et al. | β | 2014 | β |
| Pharmacogenetics and outcome with antipsychotic drugs. | Pouget JG et al. | β | 2014 | β |
| Pharmacogenetics of antipsychotic treatment in schizophrenia. | Pouget JG et al. | β | 2014 | β |
| Pharmacogenomics in the nursing literature: an integrative review. | Knisely MR et al. | β | 2014 | β |
| Polygenic scores predict alcohol problems in an independent sample and show moderation by the environment. | Salvatore JE et al. | β | 2014 | β |
| Predicting response to preoperative chemotherapy agents by identifying drug action on modeled microRNA regulation networks. | Zhu L et al. | β | 2014 | β |
| Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products. | Johnston JD et al. | β | 2014 | β |
| Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients. | Mauri P et al. | β | 2014 | β |
| Psychometric properties and validation of the Italian version of the Mainz pain staging system as a tool for pain-patients referral selection. | Samolsky Dekel BG et al. | β | 2014 | β |
| Quality control material testing and the importance of "treating it like a patient's sample". | Kavsak PA | β | 2014 | β |
| Radiation-induced brain damage, impact of Michael Robbins' work and the need for predictive biomarkers. | Prasanna PG et al. | β | 2014 | β |
| Rapid interferometric imaging of printed drug laden multilayer structures. | Sandler N et al. | β | 2014 | β |
| Reliability and Validity Assessment of Mizaj Questionnaire: A Novel Self-report Scale in Iranian Traditional Medicine. | Mojahedi M et al. | β | 2014 | β |
| Role of financial and social hardships in asthma racial disparities. | Beck AF et al. | β | 2014 | β |
| Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement. | Iglesias AI et al. | β | 2014 | β |
| Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathways. | Verhaegh W et al. | β | 2014 | β |
| Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. | Cunningham KA et al. | β | 2014 | β |
| Skin regeneration: the complexities of translation into clinical practise. | Wood FM | β | 2014 | β |
| Stabilizing autism: A Fleckian account of the rise of a neurodevelopmental spectrum disorder. | Verhoeff B | β | 2014 | β |
| Survival, momentum, and things that make me "me": patients' perceptions of goal setting after stroke. | Brown M et al. | β | 2014 | β |
| Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care. | Miller FA et al. | β | 2014 | β |
| The emerging agenda of stratified medicine in neurology. | Matthews PM et al. | β | 2014 | β |
| The ethical framing of personalized medicine. | Joly Y et al. | β | 2014 | β |
| The evolution of nanopore sequencing. | Wang Y et al. | β | 2014 | β |
| The future of genomic testing in primary care: the changing face of personalized medicine. | Bartlett G et al. | β | 2014 | β |
| The layering of auditory experiences in driving experience-dependent subcortical plasticity. | Skoe E et al. | β | 2014 | β |
| The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. | DeRubeis RJ et al. | β | 2014 | β |
| The predictive value of smoking expectancy and the heritability of its accuracy. | Treur JL et al. | β | 2014 | β |
| The promise of methylation on beads for cancer detection and treatment. | Guzzetta AA et al. | β | 2014 | β |
| The Tomorrow's Personalized Medicine - The Killer of Today's Statistical Medicine. | Cinteza M et al. | β | 2014 | β |
| The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. | Espinoza MA et al. | β | 2014 | β |
| Tibetan medicine for cancer: an overview and review of case studies. | Bauer-Wu S et al. | β | 2014 | β |
| Traditional East Asian medicine: how to understand and approach diagnostic findings and patterns in a modern scientific framework? | Birch S et al. | β | 2014 | β |
| Using systems approaches to address challenges for clinical implementation of pharmacogenomics. | Karnes JH et al. | β | 2014 | β |
| Wellness and health omics linked to the environment: the WHOLE approach to personalized medicine. | Gibson G | β | 2014 | β |
| Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing. | V Laffert M et al. | β | 2013 | β |
| An end to the myth: there is no drug development pipeline. | Baxter K et al. | β | 2013 | β |
| Appointment reminder systems and patient preferences: Patient technology usage and familiarity with other service providers as predictive variables. | Finkelstein SR et al. | β | 2013 | β |
| A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative. | Dworkin RH et al. | β | 2013 | β |
| Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials. | Berry SM et al. | β | 2013 | β |
| Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing. | Genina N et al. | β | 2013 | β |
| Best practices: The electronic medical record is an invaluable clinical tool: let's start using it. | Vrieze SI et al. | β | 2013 | β |
| BioBanking as the central tool for translational medicine CTM issue 2013. | Marko-Varga G | β | 2013 | β |
| Black African immigrant community leaders' views on participation in genomics research and DNA biobanking. | Buseh AG et al. | β | 2013 | β |
| Blood-informative transcripts define nine common axes of peripheral blood gene expression. | Preininger M et al. | β | 2013 | β |
| Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. | Miller JM et al. | β | 2013 | β |
| Building a health care workforce for the future: more physicians, professional reforms, and technological advances. | Grover A et al. | β | 2013 | β |
| Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis. | FernΓ‘ndez-de-las-PeΓ±as C et al. | β | 2013 | β |
| Clinical and economic challenges facing pharmacogenomics. | Cohen J et al. | β | 2013 | β |
| Emerging protein array technologies for proteomics. | Lee JR et al. | β | 2013 | β |
| Epigenetics and early life origins of chronic noncommunicable diseases. | Wang G et al. | β | 2013 | β |
| Etanercept in the treatment of rheumatoid arthritis. | Hunt L et al. | β | 2013 | β |
| Expanding the foundation for personalized medicine: implications and challenges for dentistry. | Garcia I et al. | β | 2013 | β |
| Exploration of macro-micro biomarkers for dampness-heat syndrome differentiation in different diseases. | Dai J et al. | β | 2013 | β |
| From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and "augmented" medicine: some considerations on Salvatore Iaconesi's clinical story. | Bragazzi NL | β | 2013 | β |
| From personalized to public health genomics. | Gibson G et al. | β | 2013 | β |
| Genomic medicine: new frontiers and new challenges. | Pasic MD et al. | β | 2013 | β |
| Histone modifications and traditional Chinese medicinals. | Hsieh HY et al. | β | 2013 | β |
| Imaging and measuring the biophysical properties of Fc gamma receptors on single macrophages using atomic force microscopy. | Li M et al. | β | 2013 | β |
| Impact of biomarkers on clinical trial risk. | Reid GG et al. | β | 2013 | β |
| [Importance of bioinformatics in personalised medicine]. | Lengauer T | β | 2013 | β |
| Incorporation of prognostic and predictive factors into glioma clinical trials. | Johnson DR et al. | β | 2013 | β |
| Is personality associated with health care use by older adults? | Friedman B et al. | β | 2013 | β |
| Linear score tests for variance components in linear mixed models and applications to genetic association studies. | Qu L et al. | β | 2013 | β |
| Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. | Smolen JS et al. | β | 2013 | β |
| Mapping the translational science policy 'valley of death'. | Meslin EM et al. | β | 2013 | β |
| Mass spectrometric protein maps for biomarker discovery and clinical research. | Liu Y et al. | β | 2013 | β |
| Meta-analysis of oro-cecal transit time in fasting subjects. | Kokubo T et al. | β | 2013 | β |
| Microneedle Biosensor: A Method for Direct Label-free Real Time Protein Detection. | Esfandyarpour R et al. | β | 2013 | β |
| MicroRNA-dependent control of the cardiac fibroblast secretome. | Latronico MV et al. | β | 2013 | β |
| Minimum detectable change in lung nodule volume in a phantom CT study. | Gavrielides MA et al. | β | 2013 | β |
| Nanoscale mapping and organization analysis of target proteins on cancer cells from B-cell lymphoma patients. | Li M et al. | β | 2013 | β |
| Nanotheranostics for personalized medicine. | Kim TH et al. | β | 2013 | β |
| New treatments for severe treatment-resistant asthma: targeting the right patient. | Chung KF | β | 2013 | β |
| Personalised medicine: a critique on the future of health care. | Savard J | β | 2013 | β |
| Personalized assisted reproductive technology. | SimΓ³n C | β | 2013 | β |
| Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. | Grant RW et al. | β | 2013 | β |
| Personalized medicine and access to health care: potential for inequitable access? | McClellan KA et al. | β | 2013 | β |
| Personalized medicine in cardiology: the time for genotype-guided therapy is now. | Cavallari LH et al. | β | 2013 | β |
| Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. | McClure JB et al. | β | 2013 | β |
| Pharmacogenomics can improve antipsychotic treatment in schizophrenia. | Xu Q et al. | β | 2013 | β |
| Pharmacogenomics in early-phase clinical development. | Burt T et al. | β | 2013 | β |
| Prediction of personalized microRNA activity. | Lee CC et al. | β | 2013 | β |
| Predictors and moderators of response to internet-delivered Interpersonal Psychotherapy and Cognitive Behavior Therapy for depression. | Donker T et al. | β | 2013 | β |
| Printing technologies in fabrication of drug delivery systems. | Kolakovic R et al. | β | 2013 | β |
| Prognosis research strategy (PROGRESS) 4: stratified medicine research. | Hingorani AD et al. | β | 2013 | β |
| Prospects of personalized medicine in cardiovascular diseases. | Lenfant C | β | 2013 | β |
| Real-time, aptamer-based tracking of circulating therapeutic agents in living animals. | Ferguson BS et al. | β | 2013 | β |
| Recent development on statistical methods for personalized medicine discovery. | Zhao Y et al. | β | 2013 | β |
| Reverse phase protein microarrays and their utility in drug development. | Sereni MI et al. | β | 2013 | β |
| Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. | Lam YW | β | 2013 | β |
| Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage. | Malm J et al. | β | 2013 | β |
| Statistical challenges in the evaluation of treatments for small patient populations. | Korn EL et al. | β | 2013 | β |
| Stratification of randomization is not required for a pre-specified subgroup analysis. | Kaiser LD | β | 2013 | β |
| Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action. | Heinemann V et al. | β | 2013 | β |
| The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system. | Gharani N et al. | β | 2013 | β |
| The DEER database: a bridge connecting drugs, environmental effects, and regulations. | Yu Q et al. | β | 2013 | β |
| The person in personalised medicine. | Doz F et al. | β | 2013 | β |
| The practice of adult genetics: a 7-year experience from a single center. | Eble TN et al. | β | 2013 | β |
| The role of personality in predicting repeat participation in periodic health screening. | Armon G et al. | β | 2013 | β |
| The role of the physician in laboratory medicine: a European perspective. | Misbah SA et al. | β | 2013 | β |
| Translational Bioinformatics Approaches to Drug Development. | Readhead B et al. | β | 2013 | β |
| Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine. | Ntziora F et al. | β | 2013 | β |
| Using Bayesian networks to discover relations between genes, environment, and disease. | Su C et al. | β | 2013 | β |
| V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins. | Zhou C et al. | β | 2013 | β |
| ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine. | Dai J et al. | β | 2013 | β |
| A curriculum for the new dental practitioner: preparing dentists for a prospective oral health care environment. | Polverini PJ | β | 2012 | β |
| An integrated framework of personalized medicine: from individual genomes to participatory health care. | Evers AW et al. | β | 2012 | β |
| A population approach to precision medicine. | Khoury MJ et al. | β | 2012 | β |
| Applications of New Technologies and New Methods in ZHENG Differentiation. | Dai J et al. | β | 2012 | β |
| A survey of public health and consumer health informatics programmes and courses in Canadian universities and colleges. | Arocha JF et al. | β | 2012 | β |
| Barriers to the use of personalized medicine in breast cancer. | Weldon CB et al. | β | 2012 | β |
| Biological monitoring of carcinogens: current status and perspectives. | Pavanello S et al. | β | 2012 | β |
| Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. | FernΓ‘ndez-de-las-PeΓ±as C et al. | β | 2012 | β |
| Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome. | FernΓ‘ndez-de-Las-PeΓ±as C et al. | β | 2012 | β |
| Challenge of evidence in individualized medicine. | Kraft K et al. | β | 2012 | β |
| Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development. | Han T et al. | β | 2012 | β |
| Considerations of sex and gender differences in preclinical and clinical trials. | Raz L et al. | β | 2012 | β |
| Developing models of haemophilia care. | Street A | β | 2012 | β |
| DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression. | Ma K et al. | β | 2012 | β |
| EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. | Thunnissen E et al. | β | 2012 | β |
| Endoscopic ultrasound fine needle aspiration: Technique and applications in clinical practice. | Tharian B et al. | β | 2012 | β |
| From bench to market: life science patents in Europe. | Rutz B | β | 2012 | β |
| Genetics and cardiovascular disease: a policy statement from the American Heart Association. | Ashley EA et al. | β | 2012 | β |
| How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care. | Baudhuin LM et al. | β | 2012 | β |
| Impedance of novel therapeutic technologies: the case of stem cells. | Zacharias DG et al. | β | 2012 | β |
| Improved classification of Alzheimer's disease data via removal of nuisance variability. | Koikkalainen J et al. | β | 2012 | β |
| Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians. | Bernhardt BA et al. | β | 2012 | β |
| Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research. | Anderson EE et al. | β | 2012 | β |
| Influence of catechol-o-methyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivors. | FernΓ‘ndez-de-Las-PeΓ±as C et al. | β | 2012 | β |
| Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. | Larghi A et al. | β | 2012 | β |
| Label-free microcavity biosensors: steps towards personalized medicine. | Amarie D et al. | β | 2012 | β |
| Leveraging informatics, mobile health technologies and biobanks to treat each patient right. | Hirsch BR et al. | β | 2012 | β |
| Making preventive medicine more personalized: implications for exercise-related research. | Buford TW et al. | β | 2012 | β |
| Modernizing US regulatory and reimbursement policy to support continued innovation in genomic pathology. | Walcoff SD et al. | β | 2012 | β |
| Molecularly-targeted and biological anti-cancer therapy. | Klener P et al. | β | 2012 | β |
| Monitoring drug therapy. | Buclin T et al. | β | 2012 | β |
| Monitoring of the effects of new-generation oral anticoagulants β what does it mean? β . | Goto S | β | 2012 | β |
| More than just an oncogene translocation and a kinase inhibitor: Kevin's story. | Costa DB | β | 2012 | β |
| Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo. | Sano D et al. | β | 2012 | β |
| Open biomedical pluralism: formalising knowledge about breast cancer phenotypes. | Sojic A et al. | β | 2012 | β |
| Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. | Pulley JM et al. | β | 2012 | β |
| Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. | Schildcrout JS et al. | β | 2012 | β |
| Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity: the case for personalized combinatorial therapies. | TschΓΆp MH et al. | β | 2012 | β |
| Overcoming regulatory and economic challenges facing pharmacogenomics. | Cohen JP | β | 2012 | β |
| Patient-oriented research in the era of personalized medicine. | Brown NJ | β | 2012 | β |
| Personalized health care: from theory to practice. | Snyderman R | β | 2012 | β |
| Personalized medicine--a tailored health care system: challenges and opportunities. | Louca S | β | 2012 | β |
| Personalized medicine: been there, done that, always needs work! | Murray JF | β | 2012 | β |
| Personalized medicine: Has it started yet? A reconstruction of the early history. | Emmert-Streib F | β | 2012 | β |
| Personalized medicine in cardiovascular diseases. | Lee MS et al. | β | 2012 | β |
| Personalized medicine in rare diseases. | Palau F | β | 2012 | β |
| Personalized medicine in Type 2 diabetes: what does the future hold? | Grant RW et al. | β | 2012 | β |
| Personalized medicine - where do we stand? Pouring some water into wine: a realistic perspective. | Gundert-Remy U et al. | β | 2012 | β |
| Personalized nanomedicine. | Lammers T et al. | β | 2012 | β |
| Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review. | Cuijpers P et al. | β | 2012 | β |
| Personalized treatment of alcohol dependence. | Kranzler HR et al. | β | 2012 | β |
| Perspectives on personalized cancer care. | Dancika GM et al. | β | 2012 | β |
| Perspectives on systems biology applications in diabetic kidney disease. | Komorowsky CV et al. | β | 2012 | β |
| Pharmacogenomics and individualized medicine: translating science into practice. | Crews KR et al. | β | 2012 | β |
| Phenotype-optimized sequence ensembles substantially improve prediction of disease-causing mutation in cystic fibrosis. | Masica DL et al. | β | 2012 | β |
| PhRMA survey of pharmacogenomic and pharmacodynamic evaluations: what next? | Grecco N et al. | β | 2012 | β |
| Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. | Sun H et al. | β | 2012 | β |
| Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). | CTSA Principal Investigators et al. | β | 2012 | β |
| Relating human genetic variation to variation in drug responses. | Madian AG et al. | β | 2012 | β |
| RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. | Wang F et al. | β | 2012 | β |
| Severe asthma in childhood: recent advances in phenotyping and pathogenesis. | Fitzpatrick AM et al. | β | 2012 | β |
| Small business development for molecular diagnostics. | Anagostou A et al. | β | 2012 | β |
| Smart surface for elution of protein-protein bound particles: nanonewton dielectrophoretic forces using atomic layer deposited oxides. | Emaminejad S et al. | β | 2012 | β |
| Standardization and utilization of biobank resources in clinical protein science with examples of emerging applications. | Marko-Varga G et al. | β | 2012 | β |
| [Tailored medicine or narcissomics?]. | RΓ¦der H et al. | β | 2012 | β |
| The influence of health care policies and health care system distrust on willingness to undergo genetic testing. | Armstrong K et al. | β | 2012 | β |
| The long and winding regulatory road for laboratory-developed tests. | Weiss RL | β | 2012 | β |
| Theranostics in primary care: pharmacogenomics tests and beyond. | Bartlett G et al. | β | 2012 | β |
| The rocky road to personalized medicine: computational and statistical challenges. | Corander J et al. | β | 2012 | β |
| Toward predictive oral and maxillofacial medicine: perspective on Zavras et al. | Edwards PC | β | 2012 | β |
| Usability of a novel clinician interface for genetic results. | Neri PM et al. | β | 2012 | β |
| Utility of genome-wide association study findings: prostate cancer as a translational research paradigm. | Turner AR et al. | β | 2012 | β |
| A European perspective--the European clinical research infrastructures network. | Demotes-Mainard J et al. | β | 2011 | β |
| Analysis of clinicians' attitudes towards pharmacogenomics. | Dodson C et al. | β | 2011 | β |
| A surveillance tool to support quality assurance and research in personalized medicine. | Khan NA et al. | β | 2011 | β |
| Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine. | Zineh I et al. | β | 2011 | β |
| Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. | Woehrl B et al. | β | 2011 | β |
| Contemporary directions in research ethics in pediatric psychology: introduction to the special section. | Drotar D | β | 2011 | β |
| Dearth of clinically useful diagnostics limits growth of personalized medicine. | Cohen J | β | 2011 | β |
| Delivering affordable cancer care in high-income countries. | Sullivan R et al. | β | 2011 | β |
| Genetic profiling in inflammatory bowel disease: from association to bedside. | Van Limbergen J et al. | β | 2011 | β |
| Genomics, health care, and society. | Hudson KL | β | 2011 | β |
| Health care providers and direct-to-consumer access and advertising of genetic testing in the United States. | Myers MF | β | 2011 | β |
| Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. | James KM et al. | β | 2011 | β |
| Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR). | European Society of Radiology | β | 2011 | β |
| New insights into asthma pathogenesis and treatment. | Szefler SJ et al. | β | 2011 | β |
| Personalised medicine for asthma management in pregnancy. | Szefler SJ | β | 2011 | β |
| Personalized medicine for cystic fibrosis: the next generation. | Ann Ashlock M | β | 2011 | β |
| Personalized vascular medicine: individualizing drug therapy. | Degoma EM et al. | β | 2011 | β |
| Pharmacoproteomics and toxicoproteomics: the field of dreams. | Yu LR | β | 2011 | β |
| Quantifying factors for the success of stratified medicine. | Trusheim MR et al. | β | 2011 | β |
| Searching for new cardiovascular drugs: towards improved systems for drug screening? | Silvester NC et al. | β | 2011 | β |
| Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. | Miller VM et al. | β | 2011 | β |
| Towards personalized medicine: exploring the consequences of the effect model-based approach. | Boissel JP et al. | β | 2011 | β |
| Translational research in retinology. | Siqueira RC et al. | β | 2011 | β |